Polymersomes for biomedical applications : surface functionalization of silicone-based polymer vesicles by Egli, Stefan
 Polymersomes for biomedical applications: surface 
functionalization of silicone-based polymer vesicles 
 
 
 
Inauguraldissertation 
 
 
zur 
Erlangung der Würde eines Doktors der Philosophie 
vorgelegt der  
Philosophisch-Naturwissenschaftlichen Fakultät  
der Universität Basel 
 
von 
Stefan Egli 
 
aus Wald (ZH) 
 
 
 
Basel 2011 
 
 
 
 i 
 
 
Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät der Universität Basel 
auf Antrag von 
 
 
Prof. Dr. Wolfgang P. Meier 
 
und 
 
Prof. Dr. Thomas Pfohl 
 
 
 
Basel, den 24. Mai 2011           Prof. Dr. Martin Spiess 
                    Dekan 
 
 
ii 
 
 
 
 
 
 
 
 
„Natürlicher Verstand kann fast jeden Grad von Bildung ersetzen, aber keine Bildung den 
natürlichen Verstand.“ 
 
Arthur Schopenhauer (1788 – 1860) 
 iii 
 
 
Acknowledgments 
 
First of all I want to thank Prof. Wolfgang Meier for giving me the opportunity to perform 
my PhD thesis in his research group. I admire his patience and the trust he gave me to 
work on my project as well as his cordiality.  
 
Also I thank Prof. Thomas Pfohl for his interest in my research work and for examining 
my doctoral thesis. Prof. Stefan Willitsch is kindly acknowledged for chairing the exam. 
 
Furthermore I thank our research group leaders, all our present and former Post-Doc 
group members. In this respect, my special thanks go to: PD Dr. Cornelia Palivan for her 
competent inputs, fruitful collaboration and for leading the group when times were 
difficult, Dr. Nico Bruns for fruitful collaboration and especially for being the greatest 
Queen fan ever! I also want to thank Dr. Ozana Onaca for her motivating attitude and 
the unfailing believe in and fight for a clean biolab, Dr. Katarzyna Kita for providing me 
precious advice with scientific issues. Great thanks to Dr. Per Rigler for introducing me in 
FCS and in the rules of publishing scientific articles. 
 
During my PhD, I supervised two master students, Martin Nussbaumer and Adrian Najer. 
They are motivated, intelligent and handsome scientists who did (and I am sure they still 
do) excellent work and I wish them all the best for their future career. 
 
This work would never be possible without the support of numerous collaborators 
outside our research group. In this respect I am thankful to Dr. Daniel Häussinger and 
Adnan Ganic (Organic Chemistry, Basel), Dr. Mohamed Chami (C-CINA, Basel), Dr. 
Barbara Fischer, Sonja Hartmann and Prof. Patrick Hunziker (University Hospital Basel), 
Ursula Sanders and Vesna Oliveri (ZMB), PD Dr. Helmut Schlaad (Max Planck Institute of 
Colloids and Interfaces), Karmena Jaskiewicz and Dr. Ingo Lieberwirth (Max Planck 
iv 
 
Institute for Polymer Research), Dr. Tina Stölzle and Prof. Nancy Hynes (Friedrich 
Miescher Institute). Dr. Charl F. J. Faul (School of Chemistry, University of Bristol) I want 
to acknowledge for his support in designing and writing a SNF post-doc proposal. 
Unfortunately, the proposal was not accepted, but therefore I learned a lot about ionic 
self-assembly and got interesting results which are presented in this thesis. 
 
Many thanks go to Mark Inglin for asking lots of tricky questions and for being always 
helpful and interested in discussions. He edited most of my manuscripts and thus added 
substantial value to their quality. 
 
From our research group I especially want to acknowledge Gabrielle Persy for numberous 
GPC measurements, Vimalkumar Balasubramanian and Pascal Tanner for fruitful co-
author collaboration, Dr. Mariusz Grzelakowski for introducing me in CROP and all other 
group members for their precious help. Also I will always remember the great activities 
like after work beers, Christmas parties, hiking tour and ski weekends we spend together. 
 
I also want to thank Dr. Dirk de Bruyn, Philipp Graf, Dr. Serena Belegrinou, Dr. Diana 
Sebök, Dr. Etienne Cabane, Dr. Thomas Schuster and Sven Kasper for spending a lot of 
their free-time with me, for being good friends and for having lots of fun. 
 
Besides all my friends from Basel, Dietlikon and other places I finally thank my family and 
Lena, who provided support and mental backup whenever it was needed. 
 v 
 
Abstract 
 
Polymersomes prepared from amphiphilic block copolymers are of great interest for 
applications in diagnostic and therapeutic medicine. In drug delivery, for instance, cargo-
carrying polymersomes that can target and attach to specific cell receptors will lead to 
greater drug efficacy and to fewer side effects. A key aspect considering such applications is 
to direct the polymersomes to a specific site in vivo, which requires the conjugation of 
targeting ligands to the surface of the polymeric self-assemblies. Such conjugation chemistry 
has in turn to fulfill several aspects comprising reaction selectivity and efficiency, stability of 
the resulting bond, biocompatibility and traceability. 
In this thesis, we present different chemical approaches of surface modification of silicone-
based block copolymer vesicles. In a first trial, the covalent attachment of oligonucleotides 
was performed by specific alkyne-azide click-chemistry conjugation. In a second trial, we 
introduced a new conjugation chemistry that achieves the criteria mentioned before by 
simple conjugation of 4-formylbenzoate (4FB) functionalized polymersomes with 6-
hydrazinonicotinate acetone hydrazine functionalized proteins and antibodies in aqueous 
buffer. To prove attachment of biomolecules to polymersomes, HyNic functionalized 
enhanced yellow fluorescent protein (eYFP) was attached to 4FB functionalized 
polymersomes, resulting in an average number of 5 eYFP molecules per polymersome. Two 
different polymersome−antibody conjugates were produced using either antibiotin IgG or 
trastuzumab. They showed specific targeting toward biotin-patterned surfaces and breast 
cancer cells. 
In addition, a new cationic silicone was synthesized, which assembles in certain aqueous salt 
solutions exclusively in vesicle structures. Because they form complexes with fluorescently 
labeled siRNA, such cationic silicone vesicles might be useful transfection agents. 
In summary, this thesis might impact the future generations and design of modern drug 
delivery systems. 
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1. Introduction 
1.1. Vesicles based on amphiphilic block copolymers –
promising candidates for biomedical applications 
 
Evolution has provided Nature with numerous sophisticated materials and strategies to 
confer viability to living organisms, even under the most extreme of conditions. If we 
consider the building blocks of a human body, which mainly consists of water but also 
lipids, peptides, nucleotides, salts and carbohydrates, it becomes obvious that such 
compounds need to be connected or to interact in specific ways to ensure viability. 
Supramolecular structures such as cell membranes, polymer materials such as proteins 
or nucleic acids and composite materials that include bones or teeth are good examples 
of how the combination of simple building blocks leads to special properties and 
functionality.  
 
Well inspired by Nature, scientists attempt to mimic known supramolecular structures, 
polymers and composites. New, artificial materials are being developed to repair or 
replace parts of the human body or to afford faster convalescence. Moreover, such novel 
materials are also intended to make various therapies more efficient. Examples include 
new biomineralization strategies that make use of polymeric materials in bone-tissue 
engineering,
[1]
 scaffolds for skin wound healing,
[2]
 the reconstitution of channel proteins 
in block copolymer membranes,
[3]
 and intelligent drug delivery carriers based on 
polymers.
[4]
 In this work we focus on vesicles formed by amphiphilic block copolymers 
for applications in the field of biomedicine and nanotechnology. 
 
Self-assembly of amphiphilic molecules to liquid crystal-like structures such as 
membranes is driven by thermodynamic forces and influenced by the molecule 
architecture.
[5]
 In this respect, the ratio of hydrophilic to hydrophobic blocks and their 
volume ratio are crucial factors to control whether bilayers, cylindrical or spherical 
morphologies are obtained.
[6]
 Upon vesicle formation in aqueous solution, the polymer is 
diluted continuously and an evolution from the bulk solid to lyotropic liquid (low 
molecular weight copolymers) or directly to the lamellar phase (high molecular weight 
copolymers) is observed (Figure 1).
[7]
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Figure 1. Isothermal illustration of molecular weight vs concentration phase diagram of 
poly(ethylene oxide)-co-poly(butyl oxide) and water. Reproduced by permission of the American 
Chemical Society.
[8]
 
 
Via sponge phases and possibly vesicular gel clusters, dispersed vesicles are formed at 
sufficiently high dilution. From the thermodynamic point of view, the free energy 
depends on the interfacial energy of the hydrophilic-hydrophobic boundary layer, which 
is influenced by the nature of the solvent and as a consequence by the hydration of the 
hydrophilic part. This interfacial energy is aimed to compensate the loss of entropy which 
occurs when amphiphilic molecules such as block copolymers aggregate to well-ordered 
microdomains.
[6]
 Other factors such as π-stacking between aromatic building blocks or 
intermolecular hydrogen bonds in the hydrophilic part of the membrane can contribute 
to the minimization of free energy. Soft and flexible polymer chains help to accelerate 
such a process, whereas rigid and stiff polymers need longer time to equilibrate.  
 
The first noteworthy attempts to deliver drugs using lipid based vesicles, so called 
liposomes, were made as early as the 1950s.
[9]
 Over years those systems improved e.g. 
by modifying the liposomes with poly(ethyleneglycol) (PEG) in order to prolong the 
circulation time in blood and to escape destruction by the reticuloendothelial system.
[10]
 
Additionally, cationic lipids that complex deoxyribonucleic acid (DNA) were used for gene 
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delivery.
[11]
 However, while liposome-based drug and gene delivery systems appear to be 
promising for therapeutic applications, they lack stability and exhibit uncontrolled 
release of the hydrophilic cargo.
[12]
 Furthermore, lipids are relatively small molecules 
that allow very limited chemical modification and functionalization. 
 
In contrast to liposomes, vesicles made of amphiphilic block copolymers, so called 
polymersomes, lend themselves to construct vesicles by a huge variety of hydrophobic 
and hydrophilic building blocks,
[13]
 allowing for the control of membrane thickness and 
thus of membrane stability and permeability.
[14]
 The diversity of building blocks can also 
be used to impart properties such as responsiveness to external or internal stimuli that 
enable the release or the activation of cargo in a controlled manner. Stimuli-triggered 
polymersomes are sensitive to parameters such as pH, temperature, light, oxidative 
stress, magnetic fields or ultrasound.
[15]
 In particular in drug delivery, such smart stimuli-
responsive systems are a prerequisite for the release of a drug at a certain location and 
at a certain time. To guide the drug-loaded polymersome to the region of interest, to 
diseased tissue in the body in the case of a drug delivery system, the vesicle outer 
surface needs to feature ligands that specifically interact with receptors present on the 
membrane of the diseased cell.
[16]
 The range of possibilities and challenges presented by 
polymersome surface functionalization is subject of this thesis, with a state of the art 
overview on this topic presented in Chapter 1.3 of this work.  
In addition to functional and stimuli-responsive properties, the block copolymer should 
also be non-toxic (biocompatible) and, ideally, biodegradable.
[17]
 The fate and behavior 
of the polymer in the human body after delivery of a drug is the final and crucial point 
determining whether the polymer can be used for therapeutic applications.  
 
 
It is now the challenge of the chemists to design and develop polymers that fulfill the 
prerequisites mentioned above and to combine the best systems to a multifunctional 
and complete product. The following section provides an overview of the most common 
synthetic routes to synthesize amphiphilic block copolymers. 
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1.2. Synthetic routes to create amphiphilic block copolymers 
1.2.1. Atom transfer radical polymerization 
 
Popular and simple methods to synthesize polymers with controlled molecular weights 
and narrow polydispersities are controlled radical polymerizations (CRP). The most often 
used type of CRP is the atom transfer radical polymerizations (ATRP), which is known to 
give a high control over the reaction. Well known polymers synthesized by ATRP are 
polyacrylates, polymethacrylates, polystyrenes, acrylonitriles and many others. The 
components needed for ATRP are 1) initiatior molecules such as mono- and 
multifunctional alkane-halides (R-X), where the halide is usually bromide or chloride. An 
important requirement is the presence of substituents around the atom containing 
halogen that are able to stabilize the initiating radicals (R•). 2) Transition metal 
complexes such as iron, ruthenium, nickel, molybdenum, etc. were applied as catalyst 
systems in ATRP. Copper is the most commonly used for polymerization reactions. 3) A 
variety of ligands has been developed in order to improve the solubility, selectivity and 
reactivity of those catalysts. Ligands such as bipyridines, aliphatic amines or phosphines 
have lone electron pairs that coordinate to the transition metal and help to form strong 
and stable complexes (Mt
n
-Y / Ligand).
[18]
 
 
The mechanism of ATRP, where a reversible halogen atom transfer reaction between a 
transition metal complex and a dormant chain occurs, is depicted in Scheme 1. 
 
Scheme 1. Mechanism of the transition-metal catalyzed ATRP.
[19]
 Reaction rates: kact (activation), 
kdeact (deactivation), kp (propagation), kt (termination) 
 
Methacrylate-based amphiphilic di- and triblock copolymers having different block length 
were synthesized by ATRP and their self-organization behavior in aqueous solution was 
investigated.
[20]
 They were found to self-assemble in micelles, compound micelles and 
vesicular structures. The same and similar methycrylate-based block copolymer systems 
were used to generate solid-supported membranes by “grafting to” and “grafting 
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from”
[21]
 approaches as well as by the interfacial adsorption of charged polymersome.
[22]
 
 
1.2.2. Group transfer polymerization 
 
More than 30 years ago, group transfer polymerization (GTP) was discovered at 
DuPont.
[23]
 It is a method for the polymerization of acrylic monomers and allows one to 
synthesize different polymer chain architectures. It is a sequential Micheael addition of 
organosilicone compounds to α,β-unsaturated esters, ketones, nitriles and 
carboxamides.
[24]
 This straightforward reaction is not sensitive to air, can be carried out 
at ambient temperatures or above, enables excellent control over polydispersities and 
over the polymer molecular weight simply through the ratio of initiator to monomer.
[25]
 
Also, the reaction is tolerant towards different functionalities, such as vinyl groups that 
would otherwise undergo polymerization during radical polymerization.
[18]
 The most 
common catalysts used for GTP are oxyanion and bifluoride.
[26]
 GTP has been applied for 
the synthesis of amphiphilic end-linked conetworks
[27]
 as well as for the synthesis of 
water soluble diblock copolymers that form micellar structures in deionized water.
[28]
 
 
1.2.3. Anionic polymerization 
 
In anionic polymerizations, monomer molecules are added stepwise to a negatively 
charged center, where the charge is transferred to the new end. Monomers suitable for 
anionic polymerization should have electrophile groups being able to stabilize the charge 
by resonance, e.g. esters and nitriles of acrylic acids, methacrylic acids or vinyl 
ketones.
[29]
 We differentiate between two mechanisms for the initiaton of the anionic 
polymerization (Scheme 2). 
 
 
Scheme 2. Mechanisms for the initiation of anionic polymerization. Monomer species (M), ionic or 
ionogenic species (I
-
) and electron (e
-
). 
 
In a), the carbanion is formed by adding the anion of an ionic or ionogenic species to the 
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vinyl double bond. Commonly used initiators for this kind of initiation are KNH2, n-butyl 
lithium and Grignard reagents.
[24]
 Mechanism b) describes the direct transfer of an 
electron from a donor, such as alkali metals, to the monomer to form a radical anion.
[24]
 
The anionic centers at the polymers stay reactive, even when all monomer is depleted, 
and can be quenched by terminating agents having certain functionalities. By quenching 
the reaction one can induce certain functionalities, e.g. with carbon dioxide, the polymer 
has a carboxylic acid end group, by using ethylene oxide one obtains an alcohol.
[30]
  
 
Anionic polymerization is one of the preferred methods to synthesize silicone polymers, 
which are of special interest in this work. Its main advantage, compared to e.g. the acid 
catalyzed polycondensation,
[3b]
 is the narrow molecular weight distribution of the 
product and better control over reaction. There are several sources reporting the anionic 
polymerization of silicone polymers.
[31]
 An attractive route for the synthesis of 
monofunctional poly(dimethylsiloxane) (PDMS) is described by Kazama et al.
[31c]
 They 
used n-butyllithium to initiate the anionic ring opening polymerization of 
hexamethylcyclotrisiloxane, which was finally quenched using dimethylchlorosilane. The 
resulting silane-terminated PDMS could be easily funtionalized by the hydrosilation 
reaction with allyl-functional molecules, comprising different functionalities, in the 
presence of platinum catalyst. Due to its low molecular weight distribution, the 
commercial PDMS we used in this work was probably synthesized by anionic 
polymerization. 
 
1.2.4. Polycondensation 
 
Polycondensation is a typical step-growth polymerization reaction. In a stepwise reaction 
of monomers small molecules such as water, or in the case of the acid-catalyzed 
synthesis of PDMS, methanol are eliminated.
[24]
 Some examples of polymers synthesized 
by step-growth polymerization are polyesters, polyamides, polyurethanes, 
polyanhydrides and, mostly important for us, polysiloxanes. In this work we made use of 
the acid-catalyzed polycondensation reaction to obtain bifunctional PDMS polymer. This 
reaction, which was traditionally used for the synthesis of amphiphilic, PDMS-based 
block copolymers in our group,
[3b]
 is not sensitive to moisture and therefore easy to 
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handle. In comparison to the anionic polymerization, a dramatic drawback is the rather 
poor molecular weight distribution of the resulting polymer. 
 
1.2.5. Cationic polymerization 
 
Compared to other polymerization techniques, the cationic polymerization is rarely used 
for technical applications.
[24]
 The main advantage is the control of its reactivity by the 
solvent. Disadvantages are its sensitivity towards traces of water and impurities, what 
makes the use of Schlenk techniques to carry out the polymerization reaction 
indispensable. Additionally, low temperatures are required to obtain polymers with high 
molecular weights. 
 
The initiation of cationic polymerization can be classed in three groups: a) carbenium ion 
salts; b) common protonic acids such as HCl, H2SO4 and HClO4; c) Friedel-Crafts catalysts 
or Lewis acids such as BF3, AlCl3, TiCl4 and SnCl4.
[24]
 Besides the variation of initators, 
there are also different monomers being capable for cationic polymerization. In this 
regard, electron-rich alkene derivatives having electron donor substituents, 
heteronuclear double and triple bonds as well as heteroatomic cyclic molecules should 
be mentioned. 
 
In this work we pay special attention to the cationic ring opening polymerization (CROP), 
which makes use of the ring strain as driving force to react. Linear polymers can be 
formed from monomers such as lactones, lactams, cyclic amines and cyclic ethers after 
initiation with a cationic species.
[24]
 The CROP reaction mechanism and kinetics of cyclic 
imino ethers were studied extensively during the last four decades.
[32]
 It was shown that 
solvent polarity and composition as well as substituents of the oxazoline affect the 
polymerization reaction.
[33]
 In Chapters 2 and 3 we use the CROP of the cyclic imino ether 
2-methyl-2-oxazoline to polymerize a hydrophilic tail to the hydrophobic PDMS block, 
which finally results in amphiphilic block copolymer product. The CROP reaction 
mechanism of 2-methyl-2-oxazoline is shown in Scheme 3. 
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Scheme 3. Mechanism of the polymerization of 2-methyl-2-oxazoline: a) initiation of the reaction 
by a species R (e.g. PDMS) activated with a leaving group X (e.g. triflate or tosylate). b) propagation 
of the polymerization reaction. After all the monomer is converted, the reaction is quenched by a 
nucleophile (e.g. hydroxyl anion or secondary amines). 
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1.3. Functionalization of block copolymer vesicle surfaces 
  
Polymersomes that have assembled from amphiphilic block copolymers have proven to be 
useful tools as drug delivery systems,
[4d, 17a, 34]
 nanoreactors and sensors.
[3c, 35]
 The 
attachment of targeting ligands or enzymes to the polymersomes, as well as the 
immobilization of polymer vesicles on surfaces, is of crucial importance in most of the 
previously mentioned applications. In this chapter, we will review the chemical methods that 
have been used for conjugation of a variety of ligands to the membrane surfaces of 
preformed polymersomes. The main requirements of such conjugation chemistries are their 
viability in an aqueous environment, the need to avoid cross-linking between polymersomes 
and between ligands, as well as stability and irreversibility of the resulting bond. 
Furthermore, it is desirable that the bonds are detectable and quantifiable in a simple, non-
destructive manner. The state of the art in terms of common conjugation chemistry that 
fulfills all or some of these requirements is summarized in Table 1. 
 
The first method that was used to attach ligands to the surface of preformed polymersomes 
was the biotin-streptavidin conjugation approach,
[36]
 which allows an arbitrary variation of 
ligands bearing biotin groups.
[3c, 4d, 37]
 Ligands are bound indirectly by biotin-streptavidin-
biotin interactions to the polymersome surface. The modification of block copolymers with 
biotin has been performed either by N,N'-dicyclohexylcarbodiimide/4-
(dimethylamino)pyridine-activated esterification
[3c, 4d, 37]
 or by preactivation of the terminal 
hydroxyl functionality by tresyl chloride
[38]
 or 4-fluoro-3-nitrobenzoic acid
[39]
 and subsequent 
reaction with biocytin.
[36, 39a]
 Both the esterification and the tresylation method resulted in a 
good yield of biotin modified polymer, which is essential for streptavidin and thus ligand 
binding after self-assembly of the polymersome.  
 
 12 
 
 
 
13 Introduction 
 
 
 
In order to obtain polymersomes that interact with biotin-modified ligands, biotin-modified 
block copolymers (Figure 2a) were hydrated in aqueous solution to form polymersomes that 
were then incubated in an excess of streptavidin (Figure 2b). The optimal concentrations of 
polymersomes and streptavidin need to be determined experimentally in order to avoid 
undesired cross-linking reactions. If the ratio of streptavidin to biotinylated polymersomes is 
too low, the probability of cross-linking between polymersomes increases. Once the surface 
of the biotin modified polymersome had been saturated with streptavidin, biotin modified 
ligands were then attached. 
 
 
Figure 2. Surface-modification of polymersomes exploiting biotin-streptavidin binding. a) Biotin- 
functionalized poly(2-methyl-2-oxazoline)-block-poly(dimethylsiloxane)-block-poly(2-methyl-2-
oxazoline) (PMOXA-b-PDMS-b-PMOXA). This was synthesized from the unmodified block 
copolymer by an esterification. b) Attachment of biotinylated ligands to the self-assembled 
polymersomes by a biotin-streptavidin binding approach. Reproduced by permission of Elsevier.
[4d]
 
 
The modification strategy has some possible disadvantages. Although biotin and streptavidin 
form one of the strongest non-covalent interactions known (with dissociation constant 
around 10
-15
 M),
[40]
 it is not a covalent bond. After binding, there is thus the possibility of 
ligand exchange with other biotinylated molecules in response to a change of ionic strength 
and/or temperature.
[41]
 Furthermore, streptavidin is a macromolecule of considerable size 
(52.8 kDa). Therefore, when small ligands are intended for attachment to polymersomes via 
this strategy, the atom efficiency is not very favorable and steric problems might occur.  
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The binding of fluorescent dye-modified streptavidin to biotin modified polymersomes, with 
diameters between 140 and 172 nm, was demonstrated by fluorescence imaging,
[36]
 
fluorescence correlation spectroscopy (FCS), as well as fluorescence cross-correlation 
spectroscopy (FCCS).
[37b]
 A model system, investigated by FCS and FCCS and comprising 
rhodamine-green-biotin modified polymersomes and cyanin5-labeled streptavidin, was 
utilized in order to determine the number of binding sites and the dissociation constant, KD, 
of the receptor interaction between biotin-modified polymersomes and streptavidin.
[37b]
 An 
average number of 1921 ± 357 streptavidin-Cy5 per polymersome and an intrinsic KD of 
(1.7 ± 0.4) × 10
−8
 M were determined.
[37b]
 The latter differs from the value of 10
-15
 M given in 
the literature for the biotin-streptavidin interaction, which was explained by entropic and 
steric effects. 
 
The biotin-streptavidin binding approach was used to modify polymersomes with the 
oligonucleotide polyguanylic acid (polyG), which specifically targets the macrophage A1 
scavenger receptor.
[4d]
 Moreover, the decorated polymersome has also proven to be suitable 
to target tumor cell lines.
[37a]
 The receptor-specific binding of these polymersomes in human 
and transgenic cell lines and in mixed cultures was followed by vesicular uptake. A major 
improvement in biologic efficacy was obtained for polymersomes (containing pravastatin) 
compared to free drug, whereas no increased cytotoxic effect was observed in muscle 
tissue.
[37a]
 
 
The group of Hammer has conducted extensive work on the surface-modification of 
polybutadiene-block-poly(ethylene glycol) (PBD-b-PEG) polymersomes via biotin-avidin 
interactions with the aim of creating and investigating vesicles that stick to biological 
surfaces under flow conditions, thus mimicking the adhesive properties of leucocites 
(Figure 3). The first papers in this series investigated the adhesion of biotin-decorated 
vesicles to avidin-coated surfaces.
[36, 42]
 To this end, PBD-b-PEG conjugated to biotin-lysin 
(biocytin) was synthesized. The functionalized copolymer formed vesicles on its own, or 
when mixed with unmodified block copolymers. Two different unfunctionalized block 
copolmers were mixed with the biotinylated block copolymer. One was shorter, the other 
was the same length as the functionalized polymer. Micropipette aspiration allowed 
measurement of the critical tension required to peel the membrane away from a bead 
covered with avidin as a function of biotin surface density and of the length-ratio between 
unmodified and modified block copolymers. When biocytin was conjugated to a PEG block 
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that was longer than the surrounding unmodified PEG blocks, the critical tension reached a 
maximum at a content of 55% functionalized blockcopolymer. However, when both 
copolymers were of the same length, the critical tension was maximal at 10%, after which it 
increased only marginally. Thus, the biotin end groups need to be accessible at the surface, 
while they tend to be buried in the hydrophilic polymer layer at higher concentrations. 
 
Biotinylated vesicles were coated with neutravidin, by means of which various biotin-labeled 
ligands were able to be conjugated to the surface, these include Alexa Fluor 488-biocytin, 
biotinylated adhesion molecule-1 antibody (anti-ICAM-1) and biotin-sialyl Lewis
x
 (sLe
x
; 
a selectin ligand) (Figure 3a).
[39a]
 The surface density of the antibody was tuned by varying 
the ratio of anti-ICAM-1 to sLe
x
 during the conjugation. The adhesiveness was measured 
between the decorated vesicles and ICAM-1-coated beads. In contrast to previous studies, 
the adhesion strength did not depend on the amount of biotinylated block copolymer, but 
rather increased linearly with the surface-density of the binding ligand, because the flexible 
polymer chains are buried underneath the coat of neutravidin (Figure 3b+c). Under 
physiological flow rates, such decorated vesicles do adhere to surfaces coated with 
inflammatory adhesion molecules P-selectin (to which sLe
x
 binds) and ICAM-1,
[39b, 43]
 as well 
as to inflamed endothelium,
[43]
 indicating possible applications as a targeted drug-delivery 
system.  
Although cell-specific targeting in vitro was shown with polymersomes that were surface-
modified by a biotin-streptavidin approach,
[4d, 37a]
 such polymersomes would not be of use 
in vivo studies because streptavidin is known to block essential immune reactions in the 
human body.
[44]
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Figure 3. a) Schematic illustration of biotin-coated polymersome and anti-ICAM-1-coated 
polymersome. This system was used to compare the critical tension behavior of biotinylated 
polymersomes to avidin-coated microspheres and anti-ICAM-1-coated polymersomes to ICAM-1-
coated microspheres, respectively. b) Comparison of the critical tension of those two different 
receptor-ligand pairs: biotin-avidin (open circle, dashed line) and anti-ICAM-1-ICAM-1 (closed 
circle, solid line). The divergence between the two critical tension curves is due to the variable 
manner by which the adhesion molecules were presented. c) Schematic illustration of a leukocyte-
mimicking polymersome. In order to mediate adhesion, biotinylated sialyl-Lewis X or biotinylated 
anti-ICAM-1, or both simultaneously, was (were) attached to the polymersome surface. 
Reproduced by permission of the American Chemical Society.
[39a, 43]
 
 
Another method of non-covalent but selective attachment of ligands to polymersomes and 
solid supported membranes was described by Nehring et al.
[45]
 Polymersomes were 
synthesized based on PBD-b-PEG diblock copolymer comprising carboxylic acid or lysine-
nitrilotriacetic acid (NTA) functional end groups. No disturbance of self-assembly behavior 
was observed upon mixing these two polymers. After vesicle formation, the peripheral NTA 
groups were able to form complexes with Ni
2+
 or Cu
2+
 ions. NTA-metal complexes are well 
known to selectively bind to oligohistidine sequences of proteins. Thus, maltose binding 
protein labeled with fluoresceine (His10-MBP-FITC),
[45a]
 as well as His-tagged enhanced green 
fluorescent protein (His6-eGFP)
[45]
 and red fluorescent protein (His6-RFP),
[45b]
 were able to be 
conjugated to the vesicle surface. After confirmation of the polymer-metal complex by UV-
Vis spectroscopy and electron paramagnetic resonance (EPR), dissociation constants KD of 
the different His-modified proteins to the Ni
2+
-NTA functionalized polymersome were 
determined by FCS. A KD of 7.0 ± 1.2 μM was measured for His10-MBP-FITC, 12.3 ± 1.2 μM for 
His6-eGFP and 1.99 ± 0.42 μM for His6-RFP.
[45a]
 These values are the same order of 
magnitude as the KD values obtained with Ni
2+
-NTA-modified liposomes (KD = 4.3 μM)
[46]
 and 
Cu
2+
-NTA complexes.
[47]
  
Solid supported monolayers of the same block copolymers were prepared by Langmuir-
Schaefer transfer and incubated with a His-tagged protein, with the aim of investigating 
protein binding to metal ion-complexing polymer surfaces. Atomic force microscopy (AFM) 
revealed structural details of the protein-decorated membranes, indicating that polymer 
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monolayers may induce the formation of highly ordered protein arrays. Thus, the 
immobilization of densely packed proteins to such planar surfaces is a key step for 2D 
protein crystallization.
[48]
 
 
A further type of non-covalent interaction, the binding of adamantane in the cavity of 
cyclodextrins, can be exploited to functionalize polymersome surfaces. PS homopolymer 
terminated with a permethylated β-cyclodextrin (β-CD) group,
[49]
 as well as polyether imide 
(PEI) terminated at both chain ends with β-CDs
[50]
 self-assembled into polymersomes, due to 
the hydrophilicity of the carbohydrate headgroups and the hydrophobicity of the polymer. 
The surface of these vesicles is a corona of β-CDs, which allowed the conjugation of 
adamantane-tagged horse radish peroxidase
[49]
 and adamantane-terminated PEG.
[50]
 
Isothermal titration calorimetry (ITC) and static light scattering (SLS) revealed that both the 
inner and the outer polymersome surfaces were modified with the PEG. The enzyme-coated 
polymersomes were subjected to multiple washing steps. The amount of enzyme on the 
vesicles was found to decrease, indicating that the non-covalent interaction between β-CD 
and adamantane is too weak to withstand the washing procedure.
[49]
 
 
A much more efficient and – in contrast to the biotin-streptavidin, Ni-NTA-His-tag, and β-CD-
adamantane interactions – covalent conjugation method is the Huisgen 1,3-dipolar 
cycloaddition of azides and alkynes, promoted by Sharpless and co-workers as a reaction 
that fulfills the criteria of click chemistry.
[51]
 This reaction is usually carried out in a variety of 
organic solvents such as DMF, DMSO, THF, halogenated solvents,
[52]
 or in water-alcohol 
mixtures or pure water.
[53]
 It is driven by heat or a catalytic amount of Cu(I). Because most 
polymersomes are destabilized in the presence of organic solvents, it is a prerequisite to 
perform this click chemistry conjugation reaction in aqueous media. Click chemistry with 
polymersomes in aqueous solution was introduced by van Hest and co-workers using 
poly(styrene)-block-poly(acrylic acid) (PS-b-PAA) diblock copolymers with terminal azide 
groups (Figure 4).
[54]
 Different ligands, such as an alkyne bearing fluorescent dansyl probe, 
biotin and eGFP, have been conjugated to preformed polymersomes. 
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Figure 4. Modification of the outer polymersome surface by click chemistry. Alkyne bearing 
fluorescent dansyl probe and biotin were attached to azide functionalized polymersomes. 
Reproduced by permission of the Royal Society of Chemistry.
[54]
 
 
The Cu(I) species that is used to catalyze this click reaction is usually formed in situ by mixing 
sodium ascorbate with a copper sulfate solution. In order to reach high conversion, the 
reduced Cu(I) species should be kept active for about 24 hours. For this purpose, the Cu(I) 
was stabilized by tris-(benzyltriazolylmethyl)amine (TBTA) or sodium bathophenantroline 
disulfonate (BPhT). The degree of functionalization was investigated by measuring the 
fluorescence intensity of the alkyne bearing fluorescent dansyl probe “clicked” to azide 
functionalized polymersomes. In order to find optimal reaction conditions and to improve 
the degree of functionalization of the polymersome surface, different parameters, such as 
the Cu(I) stabilizing ligands TBTA and BPhT, the copper concentration, the reaction 
temperature, and the pH of the reaction buffer, were varied. Degrees of functionalization 
between 24% and 26% were found under all conditions tested, which did not indicate a 
significant influence by the changed parameters. However, the relatively low degree of 
functionalization might be explained by functional group availability on the polymersome 
surface, with the majority of functional groups being buried in the hydrophilic layer of the block 
copolymer membrane. In addition to azide-functional polymersomes, van Hest and co-workers 
also introduced polymersomes based on alkyne-functionalized PS-b-PEG mixed with a high ratio 
of poly(styrene)-block-poly(l-isocyanoalanine(2-thiophen-3-yl-ethyl)amide) (PS-b-PIAT).
[55]
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An approach used to increase the number of surface-accessible functional groups on 
polymersomes was shown by Gillies and co-workers. By click chemistry, they attached dendritic 
and nondendritic displays of mannose, bearing alkyne functionality, to azide functional 
polymersomes and compared their binding to the mannose binding protein, concanavalin A, by 
using a hemagglutination assay.
[56]
 As shown in Figure 5, membranes functionalized with 
dendritic displays are expected to show a higher availability of the mannose ligands than the 
nondendritic ones. In fact, this hypothesis was verified by experiments that showed that the 
binding of polymersomes functionalized with dendritic mannose displays was increased by 1-2 
orders of magnitude relative to the nondendritic polymersomes. 
 
 
Figure 5. Schematic illustration of preformed polymersome membranes functionalized with (a) 
nondendritic and (b) dendritic biological ligand displays. Reproduced by permission of the 
American Chemical Society.
[56]
 
 
Polymersome-enzyme conjugates made by azide-alkyne click chemistry have been applied as 
nanoreactors for enzymatic cascade reactions.
[35e]
 Glucose oxidase (GOx) was encapsulated in 
the interior of these polymersomes and Candida antarctica lipase B (CalB) was incorporated into 
the vesicle bilayer membranes. Horseradish peroxidase (HRP) was reacted with imidazole-1-
sulfonyl azide hydrochloride to introduce azide functionalities to this enzyme.
[57]
 The HRP was 
then conjugated to the outer surface of the polymersomes via click-chemistry. The resulting 
construct had the three different enzymes partitioned in three different, well-defined local 
environments and was able to catalyze a three-step enzymatic reaction cascade, thus mimicking 
the confinement of individual reaction steps in compartments of living cells. Monoacetylated 
glucose was deprotected by CalB while diffusing from the bulk solution through the membrane 
into the cavity of the polymersome. In the cavity, the glucose was oxidized by GOx to 
gluconolactone and hydrogen peroxide. This small molecule was able to diffuse out of the 
nanoreactor through the membrane and was utilized by HRP to convert 2,2‘-azinobis(3-
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ethylbenzothiazoline-6-sulfonic acid) (ABTS) to ABTS
•+
. In order to determine the enzyme 
encapsulation and conjugation efficiencies, the enzymes were decorated with a ruthenium 
complex and the biohybrid polymersomes were analyzed by inductively coupled plasma mass 
spectrometry. More than 90% (a remarkably high percentage) of available alkyne functionalities 
on the polymersome surface were thus found to be occupied by HRP enzymes. This example 
again shows the high efficiency of the azide-alkyne click reaction in aqueous media. 
 
Reactions well-known in the field of protein conjugation chemistry, such as the reactions of 
maleimide functions with thiol groups,
[58]
 or N-hydroxy succinimidyl esters with the amine 
groups of lysins,
[59]
 can be applied to modify polymersomes bearing suitable functional 
groups on their surfaces. An example is the conjugation of the monoclonal antibody OX26 to 
poly(caprolactone)-block-poly(ethylene glycol) (PCL-b-PEG) polymersomes by reacting 
cysteine residues of the antibody with maleimido end groups of the PEG block present on 
the polymersome surface.
[60]
 These decorated polymersomes were investigated as possible 
vessels for the delivery of peptides to the brain, as the antibody binds to a receptor that can 
initiate transcytosis of particles across the blood-brain barrier. A quantity of 34 OX26 
antibodies on the surface of a polymersome was found to result in the greatest blood-brain 
barrier permeability.  
Another example of a mild conjugation reaction known in biochemistry is the addition of 
thiols to vinyl groups. This reaction was exploited to link cysteine-containing peptides to 
vesicles with a reactive surface.
[61]
 Poly(ethylene oxide)-block-poly(γ-methyl-ε-caprolactone) 
(PEG-b-PMCL) was functionalized at its hydrophilic terminus with a vinyl sulfone group. 
These block copolymers formed vesicles in aqueous solution that displayed vinyl sulfone 
groups on their surface. Short targeting peptides containing thiol groups did bind to the 
vesicles, while similar peptides lacking cysteine did not adhere. As this work was only 
recently published, future experiments are needed to show the efficiency of these peptide-
labeled polymersomes in targeted drug-delivery.  
 
Foster and co-workers reported the immobilization of polymersomes composed of PCL-b-
PEG, poly(lactide)-block-poly(ethylene glycol) (PLA-b-PEG), and poly(isoprene)-block-
poly(ethylene glycol) (PI-b-PEG), each polymer with aldehyde end groups, to aminated glass 
surfaces, resulting in a covalent imine bond (Figure 6).
[62]
 Depending on the different bilayer 
21 Introduction 
 
 
stiffnesses, the three different species of polymersomes showed different footprint areas 
upon immobilization. 
 
 
Figure 6. Covalent immobilization of aldehyde modified polymersomes on an aminated glass 
surface. Reproduced by permission of the American Chemical Society.
[62]
 
 
An extension of this concept would involve the conjugation of proteins to the aldehyde 
decorated polymersome surface, as proteins generally display a multitude of amine groups 
on their surfaces. However, this approach is unfavorable because cross-linking of 
polymersomes by proteins could occur, which would lead to large aggregates. Moreover, 
this approach would not be suitable for the formation of permanent covalent bonds in 
aqueous environments, because aliphatic imines are known to be unstable and to hydrolyze 
into their original amine and aldehyde functionalities. 
 
In this section we have reviewed a variety of synthetic routes to modify polymersome 
surfaces with moieties such as biomolecules. These methods differ by their binding 
specificities and efficiencies, by their biocompatibilities, as well as by their binding strengths. 
Non-covalent (e.g., biotin-streptavidin) and covalent binding strategies (e.g., Cu-catalyzed 
alkyne-azide click chemistry) are possible. An advantage of non-covalent binding may be that 
a higher density of functional ligands can be achieved, due to rearrangement of ligands and 
functional anchor groups. Benefits of covalent binding strategies include improved site-
specificity and reproducibility, as well as increased binding stability. The copper catalyzed 
azide-alkyne click chemistry has proven itself to be applicable to the conjugation of different 
species such as proteins, enzymes or dendrons to the polymersome surface. The use of 
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copper as a catalyst, as well as the redox conditions while reducing Cu(II) to Cu(I), are 
unfavorable for biological and pharmaceutical applications. 
 
Specific reactions to form bonds between block copolymer membranes and biological 
ligands, as well as the stability, and biocompatibility of the resulting bonds and linkers, are 
not the only points of interest when surface modified polymersomes are produced. Further 
investigations on the control of binding site availability, as well as membrane stability 
following a high degree of modification, will have to be carried out in the future. 
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1.4. Motivation and concept 
 
In the context of designing, preparing and evaluating chemically “smart” nanomaterials 
for targeted drug delivery, block copolymer-based vesicles have shown to be promising 
candidates.
[4d, 15, 63]
 The possibility to introduce miscellaneous functionalities and triggers 
and also their stability makes them favourable compared to lipid-based systems. Despite 
remarkable advances in the development of polymersomes for targeting purposes, no 
adequate chemical method to attach biomolecules in a specific, biocompatible, stable 
and simple way to their outer surface has been reported to date. Moreover, no detailed 
investigation on the stability of the self-assembly upon ligand attachment has been done. 
 
In this respect, we aim to develop a new generation of surface functionalized vesicles, 
which are based on amphiphilic block copolymers. The major advantages that our system 
should offer compared to well-known lipid and also polymer-based drug delivery systems 
are:  
 
(i) Functionality on the hydrophilic end of the block copolymer that enables 
simple, versatile modification after vesicle formation in aqueous solution 
(ii) a specific conjugation chemistry that enables specific, biocompatible, covalent 
attachment of biomolecules to the polymersome surface 
(iii) Reproducible, predictable and exclusive self-assembly followed by extrusion to 
uniform, nanosized vesicle morphologies 
(iv) Mechanical and chemical membrane stability as well as impermeability towards 
hydrophilic payload 
 
In order to realize these objectives, silicone-based di- and triblock copolymers with 
poly(2-methyloxazoline) as hydrophilic part were prepared. Polymersomes assembled 
from PMOXA-b-PDMS-b-PMOXA triblock copolymers were previously shown to be – due 
to their stability and non-toxicity – adequate drug delivery vehicles.
[4d, 37a]
 Furthermore 
they have proven to be impermeable to hydrophilic cargo
[64]
 and to act as 
nanoreactors.
[35f]
 
In this work, two established conjugation approaches being well known for their 
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specificity, efficiency and stability were used for the polymersome-ligand conjugation: 
the copper catalyzed alkyne-azide click chemistry that was introduced by Sharpless
[51]
 
and applied to polymersomes by van Hest
[54]
 and a benzaldehyde-hydrazinonicotinamide 
conjugation chemistry.
[65]
 New synthesized block copolymers as well as their self-
assembled structures in aqueous solution were characterizded by spectroscopic and 
chromatographic methods. Successful ligand conjugation to polymersomes was 
demonstrated by fluorescence correlation spectroscopy. Finally, the specific targeting to 
functional surfaces or to certain receptors, expressed by cancer cell lines, was visualized 
by fluorescence imaging and verified by cell sorting experiments. 
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2.1. Introduction 
 
Previously, we established methods to produce functional nanocontainers based on 
amphiphilic block copolymers with ideal properties for drug delivery applications.
[1]
 Here, 
we present a new strategy for specific cellular targeting by applying click chemistry in 
order to covalently attach oligonucleotides to polymeric nanocontainers comprising the 
amphiphilic block copolymer poly(2-methyloxazoline)-block-poly(dimethylsiloxane)-
block-poly(2-methyloxazoline) (PMOXA-b-PDMS-b-PMOXA). The goal of this work was to 
create a versatile drug delivery vehicle that not only shows specific targeting towards 
diseased cells, but also fluorescent properties for imaging purposes. To achieve our goal, 
we synthesized triblock copolymers with hydroxyl, alkyne or sulforhodamine B (SRB) 
functionalities at the hydrophilic terminus. These triblock copolymers were used to form 
polymersomes with surface-exposed alkyne groups. In aqueous solution, the alkyne 
group can react specifically with azide-modified molecules by the copper(I)-catalyzed 
Huisgen 1,3-dipolar cycloaddition, as shown previously.
[2]
 
 
Macrophages play an important role in a wide range of disease states such as 
autoimmune diseases, infections, cancer or atherosclerosis. It has been shown that 
nanocontainers, functionalized with the 23 nucleotide-long polyguanosine (poly(G)23), 
were taken up by the human monocytic cell line, THP-1 macrophages, that 
overexpressed the scavenger receptor A1 (SRA1) in a specific manner.
[1a]
 However, the 
binding of the ligands to the nanocontainers was performed via biotin-streptavidin 
conjugation, which is known to be stable, but not irreversible and not covalent. 
Furthermore, streptavidin is known to block essential immune reactions in the human 
body and would thus not be of use in in vivo applications.
[3]
 Therefore, the cycloaddition 
of alkynes and azides to produce a stable triazole bond is a promising method to 
covalently attach biological ligands to polymer self-assemblies. 
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2.2. Results and discussion 
2.2.1. Synthesis of triblock copolymers 
 
The synthesis of the hydrophobic PDMS and the amphiphilic block copolymer PDMS-b-
PMOXA-b-PDMS was described previously by our group.
[4]
 In a first step, the hydroxyl 
bifunctional PDMS was synthesized by an acid-catalyzed polycondensation reaction. In a 
second step, the PDMS was reacted with trifluoromethanesulfonic anhydride and this 
preactivated species was reacted in a cationic ring opening polymerization with 2-
methyl-2-oxazoline. Finally, the polymerization reaction was quenched using a KOH 
solution in methanol, resulting in a hydroxyl-terminated triblock copolymer (ABA-1). We 
obtained an alkyne-terminated triblock copolymer (ABA-2) using N-
methylpropargylamine instead of KOH as the nucleophile to quench the reaction. The 
third polymer, comprising SRB as the terminal functionality (ABA-SRB), was synthesized 
by an esterification reaction according to a procedure described previously.
[5]
 The 
structures of the three different polymers are shown in Scheme 4. 
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Scheme 4. PMOXA-b-PDMS-b-PMOXA triblock copolymers comprising different functionalities: 
ABA-1 having a hydroxyl group, ABA-2 having a N-methylpropargyl (alkyne) group and ABA-SRB 
having a SRB group at its hydrophilic end. 
 
2.2.2. Characterization of the block copolymers 
 
The block length of the ABA polymers was characterized by 
1
H NMR using a 400 MHz 
Bruker spectrometer. Spectra of those polymers are shown in Figures 36 and 37. From 
the integral values we calculated a composition of A10B87A10 for the ABA-1 polymer, 
A7B86A7 for the ABA-2 polymer and A10B85A10 for the ABA-SRB polymer.  
 
The conjugation of SRB to the polymer was confirmed by pulsed field gradient spin echo 
1
H-NMR experiments (PFGSE), as shown in Table 2. The diffusion coefficient of the SRB-
labeled polymer (signal at 6.80 ppm) was determined as 2.41*10
-10
 m
2
 s
-1
. For the 
diffusion coefficient of free SRB acid chloride in CDCl3 (7.16 ppm), we obtained 6.04*10
-
10
 m
2
 s
-1
. Using the Stokes-Einstein equation and assuming that the molecular weight is 
proportional to a spherical volume, we calculated the molecular weight of the SRB-
labeled polymer based on the molecular weight of SRB acid chloride (577.11 g mol
-1
) and 
the two measured diffusion coefficients. We obtained an average polymer molecular 
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weight of 9085 g mol
-1
, which is in good agreement with the molecular weight calculated 
from 
1
H-NMR integrals (8756 g mol
-1
). 
 
Table 2. 
1
H NMR Chemical shifts of different functional building blocks of the block copolymer and 
SRB dye. Diffusion coefficients were measured at * and 
#
 labeled chemical shifts. 
Component δCH3-Si δCH3CON< δ>N-CH2-CH2-N< δaromatic D [m
2
 s
-1
] 10
-10
 
ABA-OH 0.1 2.0 – 2.2 3.3 – 3.5 - - 
ABA-SRB 0.1
#
 2.0 – 2.2 3.3 – 3.5 6.7 – 8.7* 2.36
#
 / 2.41* 
SRB - - - 6.7 – 8.7* 6.04* 
 
A different approach to determine whether the fluorescent dye is conjugated covalently 
to the block copolymer was the measurement of its diffusion time by fluorescence 
correlation spectroscopy (FCS) in ethanol solution. At an excitation wavelength λex of 
514 nm, the diffusion time of solutions with a polymer concentration of 1.9 μg mL was 
measured. The data we obtained for free SRB (50 nM), for ABA-SRB and for ABA-1 in a 
solution of 50 nM SRB are presented in Table 3. 
 
Table 3. Parameters obtained by FCS of free SRB, ABA-SRB and mixed free SRB and ABA-1 in 
ethanol 
Sample Count rate 
[kHz] 
N
a
 τ1 [μs]
b
 F1 [%]
c
 τ2 [μs]
b
 F2 [%]
c
 
SRB 36.5 23.5 51 100 - - 
ABA-SRB 25.6 28.5 51 0.8 124 99.2 
SRB + ABA-1 36.7 23.9 51 6.9 53 93.1 
a
Number of molecules 
b
Diffusion time of molecular species 
c
Fraction of molecules with certain diffusion times 
 
The free SRB in ethanol shows a diffusion time τ that is twice that of the diffusion time of 
free SRB in aqueous solution.
[6]
 This could be explained by the different solubility of SRB 
in ethanol as compared to water, but also the solvent viscosity (ηwater, 291 K = 1.06; 
ηethanol, 291 K = 1.22) could have a minor effect on the mobility of the dye. The ABA-SRB 
solution contained mainly species with a high diffusion time of 124 μs and only an 
insignificant fraction of 0.8% of free dye. In contrast, the sample of ABA-1 mixed with 
SRB showed two fractions with almost identical τ of 51 μs and 53 μs. The latter τ, which 
differs slightly from the diffusion time of free SRB, can be explained by the influence of 
the ABA-1 on the viscosity of the solution. However, there is a significant difference 
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between the τ of ABA-SRB and that of the mixed solution of ABA-1 and SRB, which is 
additional proof that SRB is covalently bound to ABA-SRB. 
 
2.2.3. Preparation and characterization of polymersomes 
 
Polymeric nanocontainers were prepared by mixing the three different ABA polymers in 
the following weight ratio: ABA-1/ABA-2/ABA-SRB 16.0/3.7/1.0. This mixture was 
dissolved in ethanol, the solvent was evaporated under vacuum and bidistilled water was 
added to yield a total polymer concentration of 4 mg mL
-1
. After two days hydration, the 
polymersome solution was extruded through a polycarbonate filter (0.2 μm pore size) 
and characterized by transmission electron microscopy (TEM, Figure 7), Fluorescence 
correlation spectroscopy (FCS, Figure 8), confocal laser scanning microscopy (CLSM, 
Figure 9) and by light scattering. 
 
 
Figure 7. Transmission electron micrographs of polymersomes consisting of ABA-1, ABA-2 and ABA-
SRB, stained with 2% uranylacetate solution. The scale bar represents 1 μm. 
 
We obtained information on the morphology of our self-assemblies using dynamic (DLS) and 
static (SLS) light scattering. DLS showed a hydrodynamic radius (Rh) of 126.9 nm and SLS a 
radius of gyration (Rg) of 107 nm (Guinier-plot in Figure 35). From these values, we 
obtained the ρ-value given as ρ = Rg/Rh, which provides information on the internal 
structure of our particles in solution.
[7]
 A ρ-value of 0.84 indicates that amongst vesicles, 
there are other morphologies present in our sample. The TEM image (Figure 7) shows 
collapsed vesicles, but also wormlike micelles. This indicates that the rather low ρ-value 
could be a combination of both vesicles and micelles. 
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FCS autocorrelation curves (Figure 8) clearly show the difference between freely diffusing 
SRB dye (τD = 28 μs) and the polymersomes (τD = 7.5 ms) containing ABA-SRB. The values for 
τD were found to be in an expectable range.
[6]
 By CLSM (Figure 9) we confirmed the absence 
of big aggregates. However, the optical resolution of the confocal microscope is not 
sufficient to distinguish single vesicles by CLSM. What is shown are individual fluorescent 
spots corresponding to single vesicles. 
 
Figure 8. FCS autocorrelation curves of 50 nM SRB and of a 0.5 mg mL
-1
 polymersome solution 
consisting of ABA-1, ABA-2 and ABA-SRB in bidistilled water. The applied laser excitation 
wavelength was 543 nm. 
 
 
Figure 9. Confocal laser scanning micrograph of a 0.5 mg mL
-1
 polymersome solution consisting of 
ABA-1, ABA-2 and ABA-SRB in bidistilled water. The scale bar represents 5 μm.
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2.2.4. Specific uptake of poly(G)23-modified polymersomes by 
 THP-1 cells 
 
In order to verify the specific cellular uptake we used the human monocytic cell line 
THP–1. Previous studies have shown the feasibility of specific uptake of poly(G)23 
modified polymeric nanocontainers by THP-1 cells using the biotin-streptavidin 
interaction as a link for the ligand.
[1]
 Although modular and of high affinity, biotin-
streptavidin interactions have the drawback that the number of binding sites of the 
nanocontainer has to be precisely determined in order to prevent excess free ligand 
reducing uptake significantly, and that streptavidin might lead to adverse 
immunogenicity. Therefore, we made use of azide-alkyne click chemistry to conjugate 
the poly(G)23 ligands to the polymersome surface by following a protocol from van Hest 
and co-workers.
[2]
 It was not possible to prove and quantify the conjugation of azide-
functionalized poly(G)23 ligands to alkyne-functional polymersomes by spectroscopic 
methods. A possible explanation for this is the poor solubility of oligonucleotides in 
chloroform, which is the standard 
1
H NMR solvent for our polymers, as well as the low 
concentration of poly(G)23, which makes IR and UV-Vis spectroscopy impossible. The only 
proof presented here is the specific and enhanced uptake of fluorescent vesicle-poly(G)23 
conjugates by THP-1 cells. 
 
Two days prior to imaging, THP-1 cells were activated with phorbol-12-myristate-13-
acetate (PMA, 100 nM) to differentiate the monocytes into macrophages and 
approximately 500 000 cells mL
-1
 were seeded into each well of the tissue culture slide 
(Lab-tek, NUNC). Both poly(G)23 modified nanocontainers and control ABA 
nanocontainers lacking the ligand were added to the activated cells and incubated (37°C, 
5% CO2) for 4 and 24 hours, respectively. Confocal fluorescence imaging using the 
543 nm laser line of a ZEISS LSM 510 microscope was used to determine the extent of 
specific cellular uptake (Figure 10). 
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Figure 10. Confocal laser scanning micrographs (CLSM, left) and differential interference image 
(DIC, right) images of THP-1 macrophages. a) after 4 h and b) after 24 h incubation with 
polymersomes consisting of ABA-1, ABA-SRB and ABA-2 after click-conjugation with polyG23-azide. 
c) after 24 h incubation with polymersomes consisting of ABA-1, ABA-SRB and ABA-2; without 
polyG23-azide. All cell samples were washed with PBS before imaging. 
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Significantly higher relative fluorescence intensity was found in THP-1 samples incubated 
with poly(G)23-modified polymersomes (Figure 10a+b) in contrast to THP-1 cells 
incubated with polymersomes lacking the poly(G)23 ligand (Figure 10c). By comparing 
Figure 10a and 10b, it is obvious that, after 24 h incubation time, the cells were full of 
polymersomes, whereas after 4 h incubation time there was only little fluorescence in 
the cells. This shows that the uptake is, to a certain extent, time-dependent. However, 
from Figure 10c it is clear that there is some unspecific uptake of polymersomes after 
24 h incubation time as well. The ABA-SRB, which exhibits charged, hydrophilic SRB 
groups at its hydrophilic end, might also have an effect on the polymersome uptake. 
Since both the poly(G)23-labeled and the control polymersomes contain ABA-SRB, this 
effect should be about the same for both samples. 
 
2.2.5. Scission of biological ligands under click-conditions 
 
When we tried to conjugate antibodies and bovine serum albumin (BSA) to polymersomes 
by click chemistry, we obtained results that indicated no binding of the ligands to the 
polymersomes (measured by FCS, data not shown). This lets us assume that reactions other 
than the click conjugation can occur in our system. It has been shown that ascorbate redox 
systems are able to form OH-radicals in the presence of copper and O2 under physiological 
conditions.
[8]
 Such radicals are considered to be responsible e.g. for the scission of 
polysaccharides
[9]
, peptides
[10]
, proteins
[11]
 and nucleic acids
[12]
. This makes clear that the 
conjugation of biomolecules under click chemistry conditions in aqueous solution is 
unfavorable for pharmaceutical and biomedical applications. 
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2.3. Conclusion 
 
Here, we have presented the functionalization of polymersomes by linking poly(G)23 
ligands to the outer vesicle membrane by the copper catalyzed azide-alkyne click 
chemistry approach. To determine whether this system is viable for targeting specific 
cells, poly(G)23 modified polymersomes were incubated with activated macrophages, 
resulting in specific cellular uptake. Even though THP-1 cell uptake results look 
promising, we were not able to show direct evidence of click conjugation of the ligands 
to the polymersomes. Furthermore it is questionable whether the use of copper as a 
catalytic agent is an appropriate option for applications such as drug delivery. In 
addition, the redox reaction of copper and ascorbate, which is unavoidable for “clicking” 
the ligands to the polymersomes, induces unwanted cleavage or scission of different 
biomolecules. 
 
The fluorescently labeled ABA-SRB was characterized in detail by a combined analytic 
approach using both 
1
H-NMR and FCS. Both of these methods indicated successful 
conjugation of SRB acid chloride to ABA-1 polymer by esterification reaction. Such 
labeled polymers are interesting materials to study the fate of polymersome drug 
delivery systems in vivo, but also e.g. the mixing behavior of different species of 
amphiphilic molecules in membranes.
[13]
 Further studies are necessary to optimize the 
covalent modification of ligands to the polymersomes, other promising receptor-ligand 
interactions have to be screened for optimal uptake and specificity, and ultimately 
release of biological active molecules has to be accomplished in order to develop a 
successful polymeric platform for targeted drug delivery. 
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3.1. Introduction 
 
Because of their considerable potential, nanoscale vesicles composed of block 
copolymers, that is, nanovesicles or polymersomes, continue to draw wide interest in 
diverse areas of nanotechnology and medical research.
[1]
 In drug delivery, for example, 
cargo-carrying polymersomes that target and attach to specific cells will lead to greater 
drug efficacy and to fewer side effects. In the field of biosensing, for example, in ELISA 
assays, polymersome-antibody conjugates have, due to their high loading capacity, the 
potential to provide a marked advantage to nanosensor design by providing elevated 
sensitivities as they report specific attachment to a variety of antigens or to 
complementary species in general. 
 
To achieve their promised potential in areas such as those indicated above, it is essential 
that nanovesicles be subject to both precise control of design and functionality, and that 
they exhibit stability. In drug delivery, nanosize vesicles have been shown to possess far 
greater load-carrying capacity as compared to simple drug-polymer conjugates for 
medicinal therapy.
[2]
 This capacity can be used for direct, site-specific transport of 
hydrophilic drug cargos such as doxorubicin
[3]
 and pravastatin,
[4]
 but also of proteins and 
nucleic acids.
[5]
 Block copolymer vesicles are leading candidates for such nanosize 
applications because they feature superior membrane stability, select impermeability, 
precise chemical control, and a resulting structural versatility that yields a prodigious 
variety of possible sizes and functionalities.
[6]
 To be effective in drug delivery, 
nanovesicles must maximize three essential features: (1) membrane impermeability to a 
hydrophilic cargo to prevent loss of drug;
[2]
 (2) reduced adhesion of protein to the outer 
surface to avoid elimination by the immune system and thus to increase circulation time 
in blood;
[7]
 and (3) stable attachment of ligands that specifically target receptors of 
diseased cells.
[8]
 Polymersomes based on poly-(dimethylsiloxane)-poly(2-
methyloxazoline) block copolymers possess these three properties
[7, 9]
 and have 
therefore been used in ligand-interaction, cell uptake, and nanoreactor studies.
[8, 10]
 To 
avoid possible interactions between targeting ligands and cargo (drugs, RNA, etc.) and to 
prevent interference with self-assembly, attachment of ligands must take place on the 
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outer polymersome surface after vesicle formation. Several approaches to attach ligands 
have been reported, for example, biotin-streptavidin binding
[8, 10a, 11]
 or azide-alkyne click 
chemistry.
[12]
 Although these approaches have proven feasible, they exhibit problems in 
terms of application in therapy, including human intolerance to streptavidin and toxic 
effects due to possible copper residues used to catalyze the alkyne-azide click reaction. 
Therefore, the challenge was to devise a biocompatible conjugation chemistry that 
would lead not only to precise control and stable chemical bonding but also to high 
selectivity while avoiding disadvantageous reaction additives and catalysts. Various 
studies have clearly shown that different species such as proteins and nucleic acids can 
be conjugated to each other by a hydrazinonicotinamide- and a formylbenzamide-
counterpart functionality, resulting in a bis-aryl hydrazone bond.
[13]
 This bond is known 
to be biocompatible,
[14]
 stable and selective,
[13a]
 and thus fulfilled our requirements. The 
reaction is efficient under mild conditions in aqueous buffer at room temperature.
[13a]
 
Moreover, an inherent advantage that follows is the ability to trace and quantify the 
formation of the covalent link between conjugated species due to the absorbance of the 
formed bis-aryl hydrazone bond.  
 
To achieve our goal, we synthesized poly(dimethylsiloxane)-block-poly(2-
methyloxazoline) (PDMS-b-PMOXA) diblock copolymers with hydroxyl or piperazyl 
functionalities at the hydrophilic terminus. The piperazyl group represents a secondary 
amine, which can react with amine-targeting linkers. These diblock copolymers were 
used to form polymersomes with surface-exposed amine groups. The number of exposed 
amines on the surface was controlled by varying the molar percentage of piperazyl 
functional polymer, as shown by attachment of a succinimidyl ester-activated 
fluorophore. 
 
We therefore applied this linker chemistry for the first time to form covalent attachment 
of biological ligands, such as proteins and antibodies, to the surface of polymersomes by 
means of the bis-aryl hydrazone bond. Using two different polymersome-antibody 
conjugates, we also demonstrate the specific targeting of biotin-functionalized surfaces 
as well as in vitro targeting of human epidermal growth factor receptor 2 (HER2),
[15]
 
which is expressed by SKBR3 human breast cancer cells. 
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3.2. Results and discussion 
3.2.1. Block copolymer synthesis and characterization  
 
We synthesized PDMS-b-PMOXA diblock copolymers to provide a polymer with 
amphiphilic properties suitable for the formation of polymersomes. As compared to the 
PMOXA-b-PDMS-b-PMOXA triblock copolymers previously studied by our group,
[5c]
 these 
diblock copolymers have a more defined composition due to their narrower distribution 
of molecular weights. Additionally, the unreacted PDMS can be easily separated from the 
diblock copolymer by centrifugation, which makes purification of the diblock copolymers 
more efficient. 
 
The polymerization of the hydrophilic PMOXA block from an activated PDMS was carried 
out as previously reported.
[9, 16]
 In our previous work, the cationic ring-opening 
polymerization of 2-methyl-2-oxazoline from the preactivated PDMS was ultimately 
quenched using a KOH solution in methanol, resulting in a hydroxyl-terminated PMOXA 
block. We obtained a secondary amine-terminated diblock copolymer (AB-NH) using 
piperazine instead of KOH as the nucleophile to quench the reaction.
[17]
 Additionally, a 
hydroxyl terminated diblock copolymer (AB-OH) was synthesized. The structures of both 
are shown in Scheme 5. 
 
 
Scheme 5. PDMS-b-PMOXA diblock copolymer structures, one having hydroxyl (1, AB-OH) and the 
other piperazyl functionality (2, AB-NH) at the hydrophilic end 
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Unreacted piperazine and other low molecular weight impurities were removed by 
ultrafiltration in ethanol. We calculated the average composition of the block copolymers 
from 
1
H NMR integral data, shown in Table 4 and Figures 32-34 (Chapter 8).  
 
Table 4. Specification of the diblock copolymer products. Mw/Mn calculated from Mn
GPC
 and Mw
GPC
. 
Sample Mn
GPC
 
[g mol
-1
] 
Mw
GPC
 
[g mol
-1
] 
Mw/Mn 
[-] 
Mn
1H-NMR
 
[g mol
-1
] 
Yield 
[g; %] 
AB-OH 5153 7785 1.51 6139 17.4; 56.7 
AB-NH 4518 7506 1.66 6185 8.30; 67.1 
 
Accordingly, the hydroxyl-terminated polymer was shown to be composed of 65 siloxane 
units and 13 2-methyloxazoline units, and the piperazinyl-terminated polymer is 
composed of 68 siloxane units and 11 2-methyloxazoline units. The yield of piperazine 
functional groups was calculated as 82%. These values correspond to a molar mass of 
6139 g mol
-1
 for AB-OH and 6185 g mol
-1
 for AB-NH. The polydispersity index Mw/Mn of 
the polymers was measured by GPC, where calculations were based on polystyrene 
standards. Mw/Mn of PDMS was found to be 1.10, that of AB-OH was 1.51, and for AB-NH 
it was 1.66. These values are slightly lower than those of triblock copolymers published 
previously.
[16, 18]
 
 
3.2.2. Polymersome formation and characterization 
 
Polymersomes were formed using the film hydration method.
[19]
 We determined the 
dimensions of the extruded polymersomes by dynamic and static light scattering (DLS, 
SLS).
[20]
 Corresponding data are shown in Table 5 and as a Guinier plot in Figure 11. From 
these values, we obtain the ρ-value given as ρ = Rg/Rh, which provides information on the 
internal structure of our particles in solution.
[21]
 
 
Table 5. Light scattering data of AB-OH and AB-NH in aqueous solution 
Polymer Rh PDI
a
 Rg Mw A2 Nagg ρ-value 
 nm  nm g mol
-1
 mol dm
3
 g
-2
   
AB-OH 96.5 0.12 89.2 ± 0.6 1.66 10
8
 5.51 10
-10
 2.70 10
4
 0.92 
AB-NH 96.4 0.09 91.6 ± 0.4 6.92 10
7
 3.65 10
-10
 1.12 10
4
 0.95 
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a
The polydispersity index from lightscattering data represents the error of Rh 
 
Because the ρ-value for an ideal hollow sphere (i.e., vesicle) is 1.0 and for solid spheres is 
0.775,
[21]
 the ρ-values of our samples, at 0.92 for AB-OH and 0.95 for AB-NH, indicate 
hollow-sphere morphologies. From the molecular weights of the polymer itself and of its 
aggregated structures, we calculated the aggregation numbers (Nagg) for AB-NH and AB-
OH. They agreed well with those of PMOXA-b-PMDS-b-PMOXA triblock copolymers 
published previously.
[16, 22]
 
 
Figure 11. Guinier plots of a) AB-OH and b) AB-NH polymersome solution in water, extrapolated to 
zero angle and concentration 
 
Transmission electron microscopy (TEM) and cryo-TEM investigations were performed to 
confirm vesicular structures. Collapsed polymersomes can be seen in the TEM 
micrograph, and in cryo-TEM images we recognize the polymersome membrane 
(Figures 12 and 13). 
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Figure 12. TEM (a) and cryo-TEM (b) micrographs of AB-OH polymersomes after extrusion (0.2 µm) 
in aqueous solution. 
 
 
Figure 13. TEM (a) and cryo-TEM (b) micrographs of AB-NH polymersomes after extrusion (0.2 µm) 
in aqueous solution. 
 
The diameters of polymersomes observed in a cryo-TEM image are, in most cases, 
smaller than those found in TEM images. The reason for this can be attributed to the 
preparation of the negative stain TEM sample, which causes drying and thus flattening of 
the polymersomes, whereas cryo-TEM conserves the native structure because the 
polymersomes are imaged in the frozen-hydrated state. Inclusions present in some 
polymersomes are smaller vesicles and micelles. The average membrane thickness of 50 
different polymersomes in cryo-TEM images was measured as 15.4 ± 0.7 nm, which is 
more than 3 times thicker than phospholipid bilayers from liposomes. Thus, we conclude 
that the relatively thick polymer membrane as well as the inclusions inside the 
polymersomes (Figure 12b) might explain the small deviation of ρ-values calculated from 
light scattering data from the ideal ρ-value for vesicles. 
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3.2.3. Effects on polymersome surface functionalization 
 
Understanding and controlling the binding site density of reactive ligands on 
polymersome surfaces is of great importance for applications such as targeted drug 
delivery.
[23]
 To investigate the effects of functional group concentration on polymersome 
surface modification, we produced different batches of polymersomes consisting of 
varying molar percentages of the reactive AB-NH and the AB-OH diblock copolymers. 
Next, a simple fluorescent dye was conjugated to the amine end groups. We decided to 
use the bright, photostable dye, Alexa Fluor 633 carboxylic acid, activated as succinimidyl 
ester (A633-NHS), as the ligand for these binding site studies, due to its excellent 
fluorescence quantum yield and good solubility in aqueous solution. Becausee it was 
previously shown that such NHS reactive fluorophores bind to secondary amines,
[24]
 we 
assume that the majority of available AB-NH binding sites are modified after incubation 
in a large excess of NHS reactive Alexa dye.  
Because the NHS group of the fluorophore hydrolyzes quickly in aqueous buffer at higher 
pH values,
[25]
 an excess of activated dye was required to ensure that accessible amines 
on the polymersome surface reacted with the ligand within an appropriate time. After 
complete reaction of polymersomes with A633-NHS, the samples were extensively 
dialyzed and finally investigated using fluorescence correlation spectroscopy (FCS). In 
contrast to conventional fluorescence spectroscopy, FCS enables the accurate detection 
of the diffusion time and brightness of single vesicles.
[10a]
 Diffusion times τD = 44 ± 4 μs 
for freely diffusing A633-NHS and τD = 5.7-9.6 ms for polymersome-A633 conjugates 
were measured. This indicates successful binding of A633-NHS to the polymersomes.  
 
The brightness of the polymersomes, and thus the degree of ligand functionalization on 
the polymersome surface, was derived from the fluorescence intensity trace. Six samples 
of each AB-NH mol % were measured to obtain statistical and representative values. By 
dividing the average polymersome brightness value by the average brightness of a single 
dye molecule, we obtained the average number of fluorophores per polymersome. In a 
sample consisting of 100 mol % of AB-OH and 0 mol % of AB-NH polymer, we measured a 
fluorescence intensity corresponding to 7.6 ± 0.9 fluorophores per polymersome. We 
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assigned this value to represent unspecific binding of the polyaromatic fluorophore to 
the polymersome membrane and thus subtracted it from all other values given below. In 
Figure 14, the interdependence of the average number of fluorophores per polymersome 
(NFP) and the mole percentage of AB-NH (xn, AB-NH) are illustrated.  
 
 
Figure 14. Average number of covalently conjugated fluorophore molecules per polymersome 
versus the molar percentage of AB-NH. The data were corrected for unspecific adsorption of 
fluorophores. 
 
Values from 0.3 to 10 mol % AB-NH fit a linear function well, which is shown by NFP = 
569.2xn, AB-NH (R
2
 = 0.991), quantitatively describing the number of fluorophores per 
polymersome. The slope in Figure 14 reflects the number of fluorophores per vesicle as a 
function of the molar ratio of AB-NH in the polymersome composition, but does not 
contain any information on the variation of the initial fluorophore or polymersome 
concentration (before conjugation) in solution. Errors in fluorescence intensity (Figure 
14) originate basically with polymersome size distribution. A saturation of dye 
attachment to the polymersome was observed at higher molar percentages of AB-NH, 
from 10 to 100 mol %. This saturation can be explained by steric hindrance by dye 
molecules that were already attached to the polymersome surface. Additionally, we 
assume that at higher xn, AB-NH phase separation of dye-modified and non-modified block 
copolymers in the membrane occurs,
[26]
 which enhances steric hindrance to further dye 
conjugation and causes fluorescence quenching.
[27]
 This assumption is supported by the 
observation of some large aggregates (with diameters up to 10 μm) found in laser 
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scanning micrographs (Figure 15) and indicates a destabilization and thus aggregation of 
the original self-assemblies. Because the illuminated sampling volume is rather small, the 
size-limiting criterion for FCS measurements being less than 1 μm
3
,
[28]
 as compared to 
those aggregates, it was not possible to obtain representative FCS results for samples 
containing more than 10 mol % AB-NH.  
 
 
Figure 15. Laser scanning micrograph of polymersomes consisting of (a) 30 mol % and (b) 
100 mol % AB-NH, after reaction with Alexa Fluor 633 NHS and dialysis. 
 
The yield of the conjugation reaction can be estimated from the equation above, and the 
Nagg value can be obtained from light scattering data. Nagg was measured to be 11200 
diblock copolymer molecules per polymersome. Thus, about 5600 of them are in the 
outer part of the polymersome bilayer membrane. In the linear range up to 10 mol % of 
AB-NH, the conjugation efficiency is 10%. At first view, this conjugation efficiency might 
be considered poor. However, by taking into account that a large excess of reagent was 
used and that some of the functional groups are presumably concealed in the hydrophilic 
corona of the polymersome, this conjugation efficiency in fact represents the surface-
accessible NH-groups.  
A further argument in favor of covalent binding of A633-NHS to AB-NH polymer is given 
by FCS diffusion measurements of polymersomes dried by lyophilization and redissolved 
in ethanol, in which polymersomes disassemble into individual diblock copolymers. Thus, 
we determined the τD of free A633-NHS and of the AB-NH-A633 conjugates. For A633-
NHS (M≈1200 g mol
-1
, 5.3 nM), we measured a τD of 91.8 ± 1.0 μs, and for the AB-NH-
A633 conjugate (0.1 μg mL
-1
), a τD of 155.8 ± 2.2 μs was found, which results in a 
 52 
 
 
theoretical molecular weight for the AB-NH-A633 conjugate of 5866 ± 248 g mol
-1
. This 
molecular weight agrees well with Mn of AB-NH diblock copolymer obtained from 
1
H NMR measurements and indicates successful covalent bonding. FCS diffusion 
measurements of a mixture of A633-NHS (5.3 nM) and AB-OH (0.1 μg mL
-1
) in ethanol 
were performed to ensure that the fluorophore was attached exclusively by covalent 
bonds and not by nonspecific interactions with AB-NH. The resulting τD of 104.6 ± 1.4 μs 
corresponds to a theoretical molecular weight of 1775 ± 71 g mol
-1
, which allowed us to 
assume that only a few, nonspecific, noncovalent bindings occurred. These experiments 
point out that our polymersomes were covalently functionalized with NHS reactive 
fluorophores in aqueous solution in a controlled, reproducible manner. However, 
because we assumed that phase separation occurs at a higher molar percentage of 
modified AB-NH (≥ 10 mol %), we ultimately used polymersomes that contained 3 mol % 
AB-NH in further conjugation reactions. 
 
 
3.2.4. Covalent attachment of enhanced yellow fluorescent protein to 
polymersomes 
 
Simple and efficient attachment of ligands to preformed membranes is of great 
importance. For drug delivery purposes, not only is the attachment of relatively small 
sugars and peptides as targeting moieties of interest, but so is the conjugation of large 
proteins and antibodies to the polymersome surface. We decided to use a conjugation 
strategy that resulted in a stable and quantifiable bis-aryl hydrazone bond based on two 
complementary heterobifunctional linkers
[13a]
 (Scheme 6).  
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Scheme 6. Modification of polymersome with succinimidyl-4-formyl benzoate (NHS-4FB) and of 
ligands (e.g., protein or antibody) with succinimidyl-6-hydrazinonicotinate acetone hydrazone 
(NHS-HyNic). In a final step the 4FB-modified polymersome and the HyNic-modified ligand 
conjugate specifically and quantitatively resulting in a covalent and stable bis-aryl hydrazone bond. 
 
As compared to other conjugation techniques, this method works under mild conditions 
in aqueous buffers at pH values between 4.5 and 8.0; more importantly, it does not 
require the use of toxic catalysts such as, for example, Cu(I), which is required for azide-
alkyne click chemistry in aqueous solution.
[12, 29]
 In previous studies, this conjugation 
chemistry was used to covalently attach biomolecules such as antibodies and 
oligonucleotides to each other.
[13a, 30]
 However, to our knowledge, it has not been used 
previously to modify polymeric self-assemblies and, in particular, not for the 
modification of block copolymer membranes. 
 
Because of its fluorescent properties, eYFP was used as a model protein ligand in our 
experiment. As outlined in Scheme 6, polymersomes were modified with succinimidyl 4-
formylbenzoate (NHS-4FB), and the ligand was modified with succinimidyl 6-
hydrazinonicotinate acetone hydrazone (NHS-HyNic). We did not modify the polymers 
with 4FB before the self-assembly to polymersomes, to avoid possible interactions 
between the fluorescent dye and the 4FB group. Also, we kept the percentage of reactive 
AB-NH polymer low, at 3 mol %, to avoid the attachment of more than one polymersome 
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to eYFP. The 4FB functionalization of polymersomes was confirmed by a colorimetric 
reaction with 2-hydrazinopyridine and by gel permeation chromatography of the 
polymer, as shown in Figure 16.  
 
 
Figure 16. (a) UV-vis spectrograph of 4-formylbenzoate modified polymersomes after dialysis 
reacted with 4-hydrazinonicotinate acetone hydrazone (λmax 350 nm) (b) Gel permeation 
chromatogram of AB-NH before (dashed line) and after (solid line) conjugation of 4FB and reaction 
with 2-hydrazinopyridine (UV detection at 354 nm). 
 
Functional succinimidyl 4-hydrazinonicotinate acetone hydrazone (S-HyNic) groups, 
being complementary reactive parts to the 4FB-modified polymersomes, were 
introduced to the eYFP.[13a] The two conjugation partners, the polymersomes and eYFPs, 
were incubated in phosphate buffer, pH 6.0, for 16 h. The absorption of the resulting bis-
aryl hydrazone bond between the polymersome and eYFP was below the detection limit, 
due to increased scattering of the polymersomes at lower wavelength, and could 
therefore not be detected via ultraviolet-visible (UV-vis) spectroscopy.  
 
Because eYFP, with its almost perfect cylindrical shape of 42 Å by 24 Å,[31] is smaller by 
an order of magnitude than polymersomes having an average diameter of 193 nm, we 
used FCS as a suitable method to investigate the binding of proteins to 
polymersomes.[10a] The average τD for free eYFP in solution was found to be 93 ± 3 μs, 
and for eYFP-polymersome conjugates it was 3.98 ± 0.57 ms. This difference in τD is 
clearly shown in the shift of the FCS autocorrelation curves (Figure 17). 
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Figure 17. Fitted FCS autocorrelation curve of free eYFP (▫) and polymersome-eYFP conjugate (▪) 
 
The FCS autocorrelation curve of the eYFP-polymersome conjugate was analyzed by a 
nonlinear least-squares fitting program,[10a] assuming one population of fluorescent 
species. This indicates binding of eYFP to the polymersome. Using the τD for eYFP and for 
polymersome-eYFP conjugates along with the known diffusion coefficient D of 
fluorescent GFPs and YFPs,[32] the theoretical Rh of the polymersome-eYFP conjugate was 
calculated using the relationship between τD and D from FCS
[10a] and the Stokes-Einstein 
equation. Assuming, in a first approximation, the eYFP and the polymersomes to be 
spherical, we calculated an Rh of 2.3 ± 0.1 nm for eYFP, and 98.3 ± 14.1 nm for the eYFP-
polymersome conjugate. A diameter of eYFP-polymersome conjugates of approximately 
200 nm is further evidence for covalent attachment of eYFP to the polymersomes. 
Polymersomes without benzaldehyde functional groups on their surfaces did not 
conjugate to eYFP (τD of 93 ± 3 μs). We calculated the average brightness of freely 
diffusing eYFP and compared it to the brightness of eYFP-polymersome conjugates. An 
average number of 5 eYFP per polymersome was determined, which is significantly lower 
than the number of, for example, noncovalently bound streptavidin to biotin-modified 
polymeric vesicles.[10a] As shown above, A633-NHS-modified polymersomes consisting of 
the same molar percentage of AB-NH had, on average, 17 covalently attached dye 
molecules per polymersome. The number of eYFP ligands was found lower by a factor 
of 3. This could be due to the difference in sizes of the protein and fluorescent dye. 
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3.2.5. Polymersome-antibody conjugates for specific surface targeting 
 
Because of their specific, strong binding to proteins and haptens, antibodies are ideal 
candidates as targeting ligands.
[33]
 We functionalized antibodies with HyNic moieties and 
attached them covalently to 4FB modified polymersomes, similar to the method as 
described for polymersome-eYFP conjugates. In the first trial, HyNic-modified antibiotin 
IgG was attached to 4FB-modified polymersomes consisting of 3 wt % AB-NH and 
containing the fluorescent dye Alexa Fluor 647 maleimide (A647-M) encapsulated inside 
the polymersome cavity. The polymersome-antibody conjugates were incubated on a 
glass slide, which was previously patterned with biotinylated bovine serum albumin 
(BSA) by a microcontact printing process.
[34]
 To avoid unspecific binding, the glass surface 
of the pattern interspaces was passivated with nonbiotinylated BSA. The surface was 
imaged by confocal laser scanning microscopy. As shown in Figure 18, the polymersome-
antibody conjugates bonded specifically to the biotinylated pattern printed on the glass 
slide. As control experiments, polymersome-anti-RBC-IgG conjugates were synthesized 
and applied to patterned surfaces (Figure 18c). No specific binding of the polymersomes 
to biotinylated surface area was observed.  
 
 
Figure 18. CLSM micrographs of a) A647-M containing polymersomes with covalently attached 
antibiotin IgG, immobilized on a biotin-BSA pattern; b) close-up view of a); and c) A647-M 
containing polymersomes with covalently attached anti-erythrocyte IgG conjugates. 
 
The packing density of immobilized polymersomes in Figure 18a+b on the glass substrate 
was sufficiently low to be able to recognize dots that possibly represent single 
immobilized polymersomes. This is due to the fact that every antibody exhibits only 
three HyNic functionalities on average, which could also be positioned at the active 
antibody binding site.
[35]
 Therefore, some antibodies might be covalently attached, with 
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their active binding site facing the polymersome surface, and thus might not be able to 
bind to the biotin-BSA pattern presented on the glass surface. Their specific antigen 
targeting properties and their high fluorescence intensities render polymersome-
antibody conjugates ideal candidates for biosensor applications such as enzyme-linked 
immunosorbent assays (ELISA). When employing conventional antibody-dye conjugates, 
an optimum in labeling should be found between underconjugation, resulting in a 
fluorescence signal that is too low, and overconjugation, resulting in a change in antigen-
binding characteristics and potentially inactivating the antibody completely with 
fluorophores.
[36]
 In comparison to those conventional labeled antibodies, the sensitivity 
of ELISA should be increased several-fold by introducing polymersome-antibody 
conjugates, due to their high loading capacity with fluorescent molecules. 
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3.2.6. Targeted uptake of polymersome-trastuzumab conjugates 
 
Targeted polymersomes have been shown to be ideal candidates to transport drugs 
specifically to diseased cells.
[8]
 Because conjugates of trastuzumab with cytotoxic agents 
have been proven to specifically target HER2-positive breast cancer cells and 
considerably improve the therapeutic index,
[37]
 we decided to use polymersome-
trastuzumab conjugates for cell targeting. SKBR3 cells incubated for 2 h with 
sulforhodamine-B-containing polymersome-trastuzumab conjugates and 
sulforhodamine-B-containing polymersomes without trastuzumab, as the negative 
control, were analyzed for qualitative uptake with CLSM (Figure 19).  
 
 
Figure 19. CLSM micrograph of SKBR3 cells after 2 h incubation with polymersome-trastuzumab 
conjugate, which encapsulated sulforhodamine B. a) Polymersome-trastuzumab located 
intracellularly and in the cell membrane, shown in the red channel; b) SKBR3 cell membrane 
stained with Deep Red, shown in the green channel; and c) overlay of the micrographs from the 
red and green channels. 
 
To distinguish the extracellular and intracellular region of the cells, the cell membrane 
was stained with Deep Red. We observed polymersome-trastuzumab conjugates located 
intracellularly, and few were present in the cell membrane (Figure 19). Very low uptake 
of polymersomes without trastuzumab as compared to polymersome-trastuzumab 
conjugates was observed under similar conditions. This clearly indicates a fast and 
specific targeted uptake of polymersome-trastuzumab conjugates in SKBR3 cells. The 
targeting effect mediated by trastuzumab to HER2 receptors expressed on SKBR3 cell is 
significant at short incubation times, for example, 2 h. For a long incubation time (24 h), 
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the difference between polymersomes with and without trastuzumab was not 
distinguishable, due to the nonspecific uptake of polymersomes without trastuzumab.  
 
The quantitative uptake of sulforhodamine B containing polymersome-trastuzumab 
conjugates in SKBR3 cells was analyzed with flow cytometry. The intensity of the 
fluorescence channel measured for cells after 1 h incubation with polymersome-
trastuzumab conjugates was 8%, and it increased up to 13% after 2 h incubation, while 
for polymersomes without trastuzumab this was less than 3% even after 2 h. This 
supports the specific uptake of the polymersome-trastuzumab conjugates as being due 
to the presence of trastuzumab as the targeting ligand. By subtracting the auto 
fluorescence of cells, an uptake of polymersome-trastuzumab conjugates of 
approximately 10% was calculated for 2 h incubation (Figure 20).  
 
 
Figure 20. Flow cytometry analysis. (a) Histogram of SKBR3 cells (red), SKBR3 cells incubated 2 h 
with sulforhodamine-B-containing polymersomes (green), and SKBR3 cells incubated 2 h with 
sulforhodamine-B-containing polymersome-trastuzumab conjugate (blue); and (b) mean 
fluorescent intensity of SKBR3 cells, incubated with sulforhodamine-B-containing polymersomes 
with and without conjugated trastuzumab for 1 and 2 h. 
 
As expected, uptake of polymersome-trastuzumab conjugates is significantly faster than 
that of polymersomes without trastuzumab, in agreement with other reported 
studies.
[38]
 Besides, the uniform shift of the histogram in the fluorescent channel clearly 
indicates that the uptake is evenly distributed in the cells. 
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3.2.7. In vitro cell proliferation inhibition activity of polymersome-
trastuzumab conjugates 
 
Trastuzumab is known to inhibit proliferation of SKBR3 cells due to its specific binding to 
the HER2 receptor on the surface of the cells.
[39]
 Therefore, the effect of polymersome-
trastuzumab conjugates on cell proliferation was studied spectroscopically via the 
formation of a colored formazan product when MTS was biologically reduced by 
metabolically active cells.
[40]
 After 24 h incubation, while polymersomes without 
trastuzumab induced an inhibition of 7-11%, polymersome-trastuzumab conjugates 
inhibited the proliferation in the range of 14-21% (Figure 21). 
 
 
Figure 21. MTS assay. Proliferation inhibition effect on SKBR3 cells with different concentrations of 
polymersome with (gray) and without trastuzumab (white) after 24 h incubation. 
 
Under similar conditions, polymersome-trastuzumab conjugates were able to inhibit 
proliferation of SKBR3 by a factor of almost 2. In addition, polymersome-trastuzumab 
conjugates inhibited cell proliferation in a dose-dependent manner (Figure 21). These 
findings allow us to consider that the conjugation to the polymersome did not affect the 
functionality of the antibody. The inhibiting effect of polymersome-trastuzumab 
conjugates as compared to polymersomes can be further improved by modulation of the 
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number of trastuzumab per polymersome, and in this respect further experiments are 
ongoing to optimize the system. 
 
3.2.8. Conclusion 
 
The goal of this work was to design and implement a simple, efficient, and universal 
method to covalently attach biological ligands, such as antibodies, to polymersomes to 
provide a platform for targeting experiments. New amphiphilic PDMS-b-PMOXA diblock 
copolymers comprising hydroxyl or amine functionalities at their hydrophilic ends were 
thereby synthesized and characterized. We were able to control covalent attachment of 
NHS-activated fluorescent dye to polymersomes in aqueous buffer by systematically 
varying the molar percentage of AB-NH in the polymersome. Polymersomes and ligands 
were modified with complementary functionalities (4FB and HyNic) to attach 
macromolecular ligands, such as eYFP or antibodies, to the polymersome surface. 
Successful conjugation of eYFP to polymersomes was proven by fluorescence diffusion 
measurements. In a subsequent step, we attached HyNic-modified antibodies to 
polymersomes that were subsequently used to target selected antigens.  
 
With potential applications such as immunoassays (e.g. ELISA) in mind, polymersome 
antibiotin-IgG conjugates were shown to specifically target biotin-patterned glass 
surfaces with a virtual absence of nonspecific binding. In addition, polymersome-
trastuzumab conjugates showed specific adherence to the HER2 receptor of SKBR3 
breast cancer cells, as demonstrated by LSM imaging and FACS experiments. The effect 
of polymer concentration and incubation times on proliferation of cells was established 
via the MTS assay; polymersomes exhibited no significant toxicity. We do not expect any 
toxic effect due to the bis-aryl hydrazone bond, because it was shown elsewhere that 
PEGylated polyamidoamine dendrimers with bis-aryl hydrazone linkages induced no 
obvious cytotoxic response in HN12 tumor cells over a period of 48 h.
[41]
 In contrast to, 
for example, copper-catalyzed alkyne-azide click chemistry, all procedures here, from 
polymersome formation to ligand attachment, can be carried out under mild, 
biocompatible conditions. This makes this system applicable to therapeutic application 
in vivo. However, further investigations on the influence of the packing density of bulky, 
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macromolecular ligands on the polymersome surface are ongoing. These should enhance 
our understanding of the polymersome-ligand conjugate attachment and uptake in cells, 
and thus lead to greater control. 
 
In a nutshell, this polymersome-ligand platform, based on bis-aryl hydrazone conjugation 
chemistry that allows multifaceted and stable attachment of targeting ligands (e.g. 
antibodies), presents new opportunities to make immunoassays more sensitive and drug 
administration more effective. 
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4. Cationic poly(dimethylsiloxane) vesicles 
 
 
 
4.1. Introduction 
 
The classical approach to predict amphiphilic properties in polymers is via the construction 
of block copolymers comprising hydrophilic and hydrophobic blocks.
[1]
 In most reported 
cases, block copolymers have simple linear architectures.
[1]
 By introducing branched or 
dendritic structures, by varying the length of the hydrophilic and the hydrophobic blocks or 
simply by using different kinds of polymers, one can influence the self-assembly in aqueous 
solution. It has been shown that vesicles based on flexible, hydrophobic 
poly(dimethylsiloxane) (PDMS) are almost impermeable to hydrophilic substances
[2]
, what 
makes them interesting candidates for drug delivery purposes as well as for nanotechnology. 
In addition, by the reconstitution of membrane proteins in PMOXA-b-PDMS-b-PMOXA 
membranes, such polymers mimic natural lipid membranes and selectively transport 
hydrophilic substances.
[3]
  
 
In contrast to polymers, lipids are built of short hydrophobic alkyl chains with hydrophilic 
charged or non-charged head groups. Additionally, they have well-defined chain lengths, 
whereas polymers, in general, have a certain molecular weight distribution, which impairs 
the reproducibility of the self-assembly. One drawback of lipid membranes is their low 
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stability and uncontrollable permeability. Presently, synthetic cationic phospholipids are the 
most widely used non-viral gene carriers.
[4]
 They form stable complexes with polyanionic 
nucleic acids – so called lipoplexes – which have been proven to be good transfection 
agents.
[5]
 
Special species that are related to lipids are bipolar amphiphiles, so called bolaform 
amphiphiles or bolaamphiphiles.
[6]
 In most cases they consist of alkyl chains as hydrophobic 
part and two polar headgroups at both ends. Such lipids are found in archaebacteria and are 
supposed to contribute to their ability to survive in extreme environments. By varying 
structure and length of the hydrophobic part, their supramolecular self-assembly and 
lyotropic properties in aqueous solution have been studied extensively.
[7]
 
 
Here we describe an approach on how to combine the advantages of short oligomers, as 
exhibited by lipids and bolaamphiphiles, with the properties of block copolymers. For the 
first time, a linear polydimethylsiloxane-based oligomer carrying positive charges on its ends 
was synthesized. In aqueous phosphate buffer solution this oligomer assembles exclusively 
in monolayer vesicles. We found that the morphology as well as the vesicle size is influenced 
by the nature and the concentration of the anion. In this respect, an effect on the vesicle size 
was observed when using the sterically demanding, hydrophilic glucose phosphate anion as 
compared to simple phosphate. By varying the molar ratio of phosphate salt to cationic 
PDMS (cPDMS) we further showed an anion concentration-dependent phase change of the 
self-assembly. From cryo-TEM investigations we proved the presence of monolayer vesicles 
that were agile and tubular at room temperature but tight and spherical at 37°C. Finally, we 
showed the ability of polyanionic siRNA to complex with the cPDMS. 
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4.2. Results and discussion 
4.2.1. Polymer synthesis and characterization 
 
The synthesis of the positively charged PDMS block was performed by a simple methylation 
reaction. As depicted in Scheme 7, an aminopropyl terminated bifunctional PDMS (DMS-
A11) was reacted with iodomethane in THF in the presence of N,N-diisopropylethylamine, 
which acted as a proton scavenger, at room temperature for 72 hours. The product was 
dissolved in chloroform and extracted with potassium hydroxide solution in order to 
exchange iodine for hydroxide anions. 
 
 
Scheme 7. Methylation followed by ion exchange of aminopropyl-terminated PDMS 
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The consistency of the PDMS completely changed upon methylation, as shown in Figure 22. 
Whereas the amine-functional PDMS is a low viscosity liquid, the product, which is a 
trimethylammonium salt, had a rubber-like consistency. 
 
 
Figure 22. Aminopropyl-terminated PDMS before (A) and after (B) the methylation reaction. 
 
Complete methylation was proven by 
1
H NMR investigation (Figure 23). The resonance peak 
of the educt amine protons at 1.25 ppm disappeared upon methylation. In the product 
spectra, a new intense peak at 3.45 ppm appeared due to the ammonium methyl protons. 
From the integral values we calculated the molecular weight and could show that the 
methylation reaction was completed.  
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Figure 23. 
1
H NMR spectra of the aminopropyl-terminated PDMS educt and the methylated 
product. 
 
For the DMS-A11 we calculated an Mw of 956.9 g mol
-1
 and for the cPDMS an Mw of 1267.1 g 
mol
-1
 (assuming OH
-
 as counter ion). The difference between the Mw of the educt to the one 
of the product is higher than expected. This is explained by the loss of low molecular PDMS 
upon ion exchange extraction. 
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Further information on the composition and polydispersity of the PDMS was provided by 
matrix-assisted laser desorption / ionization time of flight mass spectrometry (MALDI-TOF-
MS). As the matrix, we used dithranol, while the sample was prepared as described 
previously.
[8]
 The MALDI spectra (Figure 24) shows dimethylsiloxane (Δ m/z = 74 g mol
-1
) as 
well as (CH3)3N
+
(CH2)3(Si(CH3)2O)3 fragments (m/z = 323 g mol
-1
). 
 
 
Figure 24. MALDI TOF mass spectra of cPDMS. 
 
Using the Voyager-DE Pro Instrument software, we calculated molecular weights and PDI 
values for DMS-A11 and cPDMS, as shown in Table 6.  
 
Table 6. Molecular weights and polydispersities as calculated from MALDI TOF MS 
Sample Mz [g mol
-1
] Mw [g mol
-1
] Mn [g mol
-1
] PDI [-] 
DMS-A11 905.94 815.39 702.41 1.16 
cPDMS 913.37 829.33 721.94 1.15 
 
In contrast to 
1
H NMR results, the differences between Mz, Mw and Mn of the educt and the 
product are lower than expected. We obtained clearly better signals for the cPDMS as 
compared to the DMS-A11, which is explained by the increased ionization / desorption 
properties of the cPDMS. The resulting low quality of the spectra of DMS-A11 has an 
influence on the calculated molecular weight values. 
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4.2.2. Self-assembly – varying the counter ion and its concentration 
 
It has been reported that the aggregation of cationic, siloxane containing surfactants is a 
sensitive function of counteranion(s) present.
[9]
 Accordingly, the relative concentrations of 
sodium salts required to favor vesicle formation were shown to follow the anion trend I < Br 
< Cl, whereas no vesicle formation was observed in concentrated NaF solution.  
In order to show such an effect with the synthesized cPDMS, we performed experiments 
using potassium phosphate and potassium glucose phosphate solutions. By confocal laser 
scanning microscopy we investigated the morphologies of cPDMS in solution which was 
stained by the hydrophobic fluorophore BODIPY®630/650. Although the cPDMS itself 
contains hydroxyl anions, it was not possible to dissolve it in double distilled water. 
Furthermore, we observed that flocculation occurs upon dissolving cPDMS in a solution of 
K2HPO4, whereas in a solution of KH2PO4 few vesicle-like structures were observed, but more 
frequently aggregates (Figure 25a). An explanation for this finding is the obviously higher pH 
in a solution of K2HPO4 than in one of KH2PO4 and thus a higher concentration of OH
-
 ions, 
which are as well counter ions to the trimethylammonium groups and competitors to the 
phosphate. 
In a solution of glucose phosphate with the same molar negative-to-positive charge ratio 
resulted in the formation of giant unilamellar vesicles (GUV) with diameters of 5 to 30 μm, as 
shown in Figure 25b. It is obvious that the size of the glucose phosphate anion has a 
significant impact on the curvature and diameter of the vesicles. Besides stabilization by the 
anionic phosphate, the glucose part is supposed to shield the vesicle membrane from other 
positively and negatively charged ions. This leads to the formation of large vesicles at 
comparably low glucose phosphate concentrations as well as to less vesicle-to-vesicle 
attachment. 
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Figure 25. CLSM (left) and transmission (right) micrographs of cPDMS self-assemblies in 
(a) monobasic phosphate solution and (b) glucose phosphate solution. The molar ratio of the 
anions to the positively charged trimethylammonium groups at the cPDMS was 10. 
 
In order to find out more about the influence of the anion concentration on the phase 
behavior, we made a series of samples in KH2PO4 solution with a varying molar ratio of 
phosphate anions to cPDMS. As shown in Figure 26, there is a clear trend from sponge-like 
aggregates (molar ratio 3 and 10) to multi-compartment vesicles (molar ratio 30) to vesicles 
(molar ratio 100 and 300). Also, we observed that vesicles at a molar ratio of 100 are larger 
than such of a molar ratio of 300. 
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Figure 26. CLSM micrographs of cPDMS self-assemblies in aqueous KH2PO4 solution, stained with 
BodiPy 630/650. The molar ratio of H2PO4
-
 ions to positively charged trimethylammonium groups is 
represented by “r” (λex = 543 nm; concentration cPDMS = 1 mg mL
-1
). 
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A general explanation of those observed morphologies is a crowding effect of the anions on 
the positively charged membrane surface. Whereas different membrane layers have to 
share a small number of anions at a low negative to positive ratio (sponge-like structures), at 
higher ratios the anions are densely packed on the membrane surface and thus force the 
formation of vesicles. At a too high ratio, lowering of the vesicle curvature occurs in order to 
increase the overall surface area. Another explanation is the differing ratio of phosphate 
anions to the original counter ion upon changing the phosphate concentration. While in this 
experiment the cPDMS and thus the cPDMS counter ion (OH-) concentration stays constant, 
the phosphate concentration changes. At lower phosphate concentration the influence of 
the OH- counter ion could be dominant and thus avoid the formation of vesicles. However, 
we cannot be sure about the mechanism that influences the vesicle formation, an anion 
concentration-dependent trend in self-assembly is clearly distinguishable. 
 
Because for most medical and pharmaceutical applications physiological phosphate buffer 
solution is required, we investigated the self-assembly characteristics of cPDMS vesicles in 
phosphate buffered saline (PBS). After extrusion through a 0.2 μm track-etched membrane 
filter the solution was characterized by light scattering and cryo-TEM. Figure 27 shows a 
Guinier-plot with different concentrations of cPDMS from 0.1 to 1.0 mg mL-1. 
 
 
Figure 27. Gunier plot of polymersomes consisting of cationic PDMS in PBS 
 
The resulting Rg was determined as 56.4 ± 0.4 nm and the average Mw of the vesicles as 
13.7 ± 1.6 × 106 g mol-1. For Rh we obtained a surprisingly low value of 14.1 ± 6.6 nm. From 
this we obtain a ρ-parameter of 4.0 ± 2.4, which is far away from the value to be expected 
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for vesicle morphologies. This result can be explained by the non-spherical, but rather 
ellipsoid shape of most of the vesicles, as shown by cryo-TEM (Figure 28). It was found for 
liposomes that the ρ-parameter for ellipsoids and other deformed spherical structures 
differs towards values larger than 1.0.[10] However, we could further show that the 
temperature of the PBS solution has an effect on vesicle shape. At ambient temperature 
vesicles are, as mentioned before, mainly ellipsoids (Figure 28A), whereas at 37°C most 
vesicles present a spherical shape (Figure 28B). 
 
 
Figure 28. Cryo-TEM of cPDMS vesicles in PBS. (A) initial sample temperature 25°C; (B) initial 
sample temperature 37°C. 
 
Therefore, we assume that the values obtained for light scattering at ambient temperature 
should be regarded with suspicion. However, more precise values could be obtained by 
small-angle X-ray scattering, which was not performed in the frame of this work. From the 
membrane thickness and the contrast characteristics shown in TEM images, we can assess 
that the membrane is a monolayer with a thickness of 3.0 ± 0.1 nm (value and standard 
deviation out of 50 measurements). The maximum theoretical thickness of the membrane is 
about 4.0 nm (considering the Si-O bond length to be 1.63 Å and the bond angle 130°). From 
those values we can assume that the PDMS molecules exhibit around 75% of their maximum 
length. Furthermore, no micelles could be found in TEM, which supports our concept of the 
cPDMS positive charges that force the system to form a membrane instead of the 
unfavorable micelles. 
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4.2.3. Complexes of siRNA with cationic PDMS in physiological buffer 
 
Cationic lipids have been shown to be effective agents to complex and deliver nucleic acids 
into cells, both in vitro and in vivo.[11] In this respect, our aim was to show the potential of 
cPDMS to complex polyanionic nucleic acids. CyTM3 labeled GAPDH siRNA was mixed with 
cPDMS during and after vesicle formation. In the sample where siRNA was added after 
vesicle formation, we observed homogenously fluorescent vesicle membranes (Figure 29). 
From this finding we assume that siRNA uniformly coats the surface of PDMS vesicles, 
without rupturing their structure. When adding siRNA during vesicle formation, we observed 
single fluorescent spots evenly distributed throughout the sample. We assume that these 
are lamellar or helical complexes of cPDMS with siRNA.[12] 
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Figure 29. CLSM (top), transmission (middle) and merge (bottom) images of cationic PDMS vesicles 
and Cy3-labelled siRNA in PBS buffer. The siRNA was added after (left) and before (right) vesicle 
formation. 
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This assumption is supported by TEM images (Figure 30), where mesh-like structures are 
shown. We have not found similar structures in samples where the siRNA was added after 
vesicle formation or in samples lacking siRNA. Such mesh-like structures potentially originate 
from continued aggregation and growth of the siRNA-cPDMS complexes.[11] 
 
 
Figure 30. TEM image of a cPDMS sample where siRNA was added during vesicle formation 
 
However, the results presented here only give a hint as to how cPDMS complexes with siRNA 
and related nucleic acids. More detailed and systematic experiments need to be performed. 
In particular, the effects of concentration and ionic strength on the cPDMS-siRNA complex 
should be investigated. In addition, the whole procedure on how to complex nucleic acids 
with cPDMS should be improved. As desirable result small rods or spheres with diameters of 
a few nanometers should be obtained. Such species are supposed to enable optimal 
transfection efficiency.[4] 
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4.3. Conclusion 
 
We designed and synthesized a linear, bolaamphiphile-like cationic PDMS by a simple 
methylation reaction. It was shown that the assembly of this material in aqueous solution is 
strongly influenced by the nature and concentration of salts and especially of their anions. In 
this respect, glucose phosphate, which is a comparably bulky, hydrophilic anion, could 
induce the formation of large, well-separated vesicles at low glucose phosphate 
concentrations. In contrast, more than the 10-fold concentration of phosphate anions was 
necessary to induce the formation of small, agglomerated vesicles. In the frame of this work, 
the influence of the pH on the self-assembly of cPDMS was not investigated. This is 
definitively one of the points that should be considered for future experiments and which 
could help to control vesicle formation. 
 
Few preliminary results on the complexation of cPDMS with siRNA were presented in the 
frame of this chapter. We could show the attachment of siRNA to the membrane of vesicles 
composed of cPDMS. However, important data on the stability as well as on the structure of 
those complexes could not be shown and should be investigated by fluorescence correlation 
spectroscopy and small-angle X-ray scattering. Finally, in vitro and in vivo experiments 
should proof the transfection efficiency of those complexes and being compared to the 
effect of established transfection agents (e.g. cationic lipids). 
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5. General conclusion and outlook 
 
In this work we presented the synthesis and characterization of novel amphiphilic tri- 
and new diblock copolymers based on PDMS and PMOXA comprising different functional 
groups at their hydrophilic ends. Their self-assembled structures, in general vesicles, 
presenting the respective functionality on the surface, could be covalently coupled with 
biological ligands by copper catalyzed click chemistry or by the specific interaction of 4-
formylbenzoate and 6-hydrazinonicotinate resulting in a stable bis-aryl hydrazone bond. 
In addition, cationic PDMS was synthesized, characterized and it’s self-assembly, 
depending on the counter anion, was investigated. The main findings of this work are: 
 
 Polymersomes assembled from ABA-1 (hydroxyl), ABA-2 (alkyne) and ABA-SRB 
were modified with azide-functional poly(G)23 oligonucleotide strands by copper 
catalyzed click chemistry. We showed that such polymersomes were taken up by 
THP-1 cell lines in a time-dependent manner. Even though uptake of 
polymersomes by cells was shown, we could not directly proof the binding of the 
poly(G)23 ligands to the polymersome surface. Due to the insufficient water 
solubility of some of the reagents involved, it was difficult to control this click 
reaction in aqueous solution. 
 The sulforhodamine B functionalized triblock copolymer ABA-SRB has proven to 
be useful for the labeling of polymersomes for in vitro fluorescence imaging. 
 For the first time, PDMS-b-PMOXA diblock copolymers were synthesized. They 
assembled to stable and water impermeable vesicles. Via the specific and 
biocompatible reaction of 4-formylbenzamide and 6-hydrazinonicotinamide 
functionalities, a stable and traceable bis-aryl hydrazone bond between the 
vesicles and biomolecules was obtained. We could show the specific cell targeting 
of polymersome-antibody conjugates without toxic effects. 
 To a short amino-bifunctional silicone, cationic charged trimethylammonium 
groups were introduced via a simple methylation reaction. The rubber-like 
product was shown – depending on the nature and properties of the counter 
anion – to assemble to unilamellar vesicle structures in aqueous solution. They 
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could potentially find application as transfection agent. 
 
Based on the results listed above, the following points are suggested for further 
investigation: 
 
 The cationic ring opening polymerization of 2-methyl-2-oxazoline to the pre-
activated PDMS is very sensitive to moisture and impurities. Furthermore, only 
few solvents are suitable for the resulting block copolymer, which is a limiting 
factor for e.g. the use of microwave-assisted synthesis of well-defined poly(2-
methyloxazolines). Therefore, a more robust method for the synthesis of PDMS-b-
PMOXA block copolymers is desirable. 
 By mixing PDMS-b-PMOXA diblock copolymers being different in the PMOXA chain 
length, we foresee a higher degree of ligands exposed at the polymersome 
surface. In this respect, also dendron-like pending structures could help to 
improve the conjugation efficiency. 
 The polymersome platform presented here has shown to be rather stable. A 
combination with a triggered release system would be beneficial in order to 
release the cargo at a specific site and finally to show a therapeutic effect in vitro 
and in vivo. 
 In the course of this work, the cationic PDMS could not be examined in great 
detail. To expand the information obtained in this work and to obtain clear 
trends, systematic self-assembly experiments of the cationic PDMS in salt 
solutions differing in ion strength and anion size should be performed. 
Furthermore, the complexation of the cationic PDMS with siRNA or DNA should be 
further investigated by FCS and small-angle X-ray scattering and the applicability 
as transfection agent should be considered. 
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6. Experimental part 
6.1. Experimental part 
6.1.1. Materials 
 
Reagents and materials were of the highest commercially available grade and were used 
without further purification, unless indicated. Monocarbinol-terminated 
polydimethylsiloxane (AB146681, MnGPC = 5633 g mol
-1, MwGPC = 6332 g mol
-1, Mw/Mn = 
1.12, Mn
1H-NMR = 5323 g mol-1) was purchased from ABCR GmbH, Germany. 2-Methy-2-
oxazoline, triethylamine, triflic anhydride and all solvents were purchased from Sigma 
Aldrich in highest quality. The crosslinkers succinimidyl-4-formyl benzoate (S-4FB) and 
succinimidyl 6-hydrazinonicotinate acetone hydrazone (S-HyNic) were purchased from 
Solulink. Anti-biotin-IgG antibodies were purchased from antibodies-online GmbH 
(Aachen, Germany), trastuzumab (Herceptin®) was provided by the University Hospital 
Pharmacy of Basel. SKBR3 cell culture was provided by the group of Nancy Hynes 
(Friedrich Miescher Institute, Basel). Dulbecco's Modified Eagle Medium (DMEM, GIBCO), 
fetal bovine serum (FBS), penicillin and streptomycin (Sigma Aldrich), phosphate-
buffered saline (PBS) (Sigma-Aldrich) were used as received. Sulforhodamine B, Alexa 
Fluor® 647 maleimide, Alexa Fluor® 633 NHS and CellmaskTM Deep Red were purchased 
from Invitrogen. 
6.1.2. Polymer synthesis 
 
PDMS synthesis was performed by an acid-catalyzed polycondensation reaction of 
dimethoxydimethylsilane in the presence of aqueous hydrochloric acid and end-capper, 
resulting in butylhydroxy-terminated bifunctional PDMS. The detailed synthesis and 
purification procedure is described elsewhere.[1] 
 
For the synthesis of PMOXA-b-PDMS-b-PMOXA triblock copolymer (ABA), PDMS was 
purified by vacuum stripping at 80°C and precipitation in an equal (by weight) 
water/methanol mixture. Purified PDMS was reacted with triflic acid anhydride in hexane 
at -10°C for 3 hours, resulting in triflate-PDMS bifunctional macroinitiator. The reaction 
mixture was then filtered under argon through a G4 filter. Hexane was evaporated under 
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vacuum and dry ethyl acetate was added as reaction solvent. Addition of dry 2-methyl-2-
oxazoline resulted in symmetric ring-opening cationic polymerization of PMOXA blocks 
on the macroinitiator. The reaction was terminated by addition of either 0.1 M 
potassium hydroxide solution in methanol (to result in the hydroxyl endfunctional 
polymer ABA1) or by N-methylpropargylamine (to result in the alkyne endfunctional 
polymer ABA2). The polymers were purified by extensive ultrafiltration (UF) in a 1/1 
water/ethanol mixture (MWCO 5000 g mol-1). 
 
The sulforhodamine B labelled PMOXA-b-PDMS-b-PMOXA triblock copolymer was 
synthesized by an esterification reaction. Hydroxyl endfunctionalized ABA polymer 
(1 equivalent) was dried under vacuum and dissolved in dry chloroform. After the 
solution was cooled to 8°C, triethylamine (TEA, 2 equivalent) and a concentrated solution 
of sulforhodamine B acid chloride (10 equivalent) in CHCl3 was added dropwise and the 
reaction mixture was allowed to stir for 24 hours at 8°C. CHCl3 was evaporated at 40°C 
and the dark red solid was dissolved in ethanol. Non-reacted free SRB and TEA were 
removed by extensive UF in pure ethanol (MWCO 5000 g mol-1). After evaporation of 
ethanol we obtained a dark red solid product (reaction yield = 95%). 
 
Synthesis of PDMS-b-PMOXA-hydroxyl and PDMS-b-PMOXA-piperazinyl diblock copolymers. 
All reaction steps were carried out under an inert argon atmosphere. The amounts used 
for the syntheses are listed in Table 7.  
 
Table 7. Amounts of educts used for the synthesis. Monocarbinol terminated 
poly(dimethylsiloxane) (PDMS), 2-methyl-2-oxazoline (MOXA), triethylamine (TEA) and 
trifluoromethanesulfonic anhydride (TfSA) 
Sample PDMS 
[g; mmol] 
MOXA 
[g; mmol] 
TEA 
[g; mmol] 
TfSA 
[g; mmol] 
AB-OH 26.62; 5.0 8.68; 100 0.524; 5.2 1.47; 5.2 
AB-NH 10.00; 2.0 5.61; 66 0.213; 2.1 0.60; 2.1 
 
PDMS was put into a three-neck, round-bottomed flask and evacuated under stirring 
over night at 60 °C. Dry hexane was added under an argon atmosphere and the solution 
was dried for 24 h by reflux in a Soxleth apparatus containing a molecular sieve 4A (Chemie 
Uetikon AG, Switzerland). 
 88 
 
 
After cooling to room temperature, triethylamine (dried over CaH2 and freshly distilled) 
was added. The solution was cooled to -10 °C and trifluoromethanesulfonic anhydride 
(TfSA) in 15 mL of dry hexane were added slowly over 30 minutes. After completion of 
the addition, the mixture was reacted for 3 h at 10 °C. Hexane was evaporated at room 
temperature in vacuum. The residual PDMS oil was redissolved in cold hexane and 
separated from triflate salt by filtration at 0 °C through a glass frit. The hexane was again 
evaporated, dry ethyl acetate and 2-methyl-2-oxazoline, previously dried and distilled 
over calcium hydride, were added. The reaction mixture was stirred for 60 h at 40 °C. 
Finally, the solution was cooled to room temperature, 5 mL of 1.0 M potassium 
hydroxide solution in dry methanol (for AB-OH synthesis) and 20 mL of 1.0 M piperazine 
solution in dry methanol (for AB-NH synthesis) were added. After 1 h ethyl acetate was 
removed under vacuum to obtain the transparent, rubber-like raw product. 
The raw product was suspended in bidistilled water and the pH was set to 7.0. The water 
was then removed by lyophilization. The polymer was dissolved in ethanol and 
centrifuged (4000 rpm for 40 minutes) to separate unreacted, non-ethanol soluble 
PDMS. Subsequently the ethanol solution was transferred into a solvent-resistant, stirred 
ultrafiltration device (Millipore, USA) equipped with a 3000 MWCO regenerated cellulose 
membrane (Millipore, USA) and extensively washed with ethanol. The ethanol solution 
was then evaporated. The resulting transparent, rubber-like diblock copolymer was 
characterized and stored under dry conditions. Yields and characterization data of the 
PDMS and the diblock copolymers are shown Table 8. 
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Table 8. Specification of the diblock copolymer products. Mw/Mn calculated from Mn
GPC
 and Mw
GPC
. 
Sample Mn
GPC 
[g mol-1] 
Mw
GPC 
[g mol-1] 
Mw/Mn 
[-] 
Mn
1H-NMR 
[g mol-1] 
Yield 
[g; %] 
AB-OH 5153 7785 1.51 6139 17.4; 56.7 
AB-NH 4518 7506 1.66 6185 8.30; 67.1 
 
The synthesis of cationic PDMS was carried out by a methylation reaction of aminopropyl 
terminated polydimethylsiloxane. 1.50 g (1.76 mmol) aminopropyl terminated 
polydimethylsiloxane DMS-A11 from ABCR GmbH & Co. was dissolved in 15 mL of dry 
tetrahydrofurane (THF). 3.04 g (21.2 mmol) iodomethane and 1.73 g (13.3 mmol) N,N-
diisopropylethylamine were added and the mixture was stirred under argon atmosphere 
for 65 h at room temperature. The reaction mixture contained yellowish-white 
precipitate. After evaporation of THF at 40 °C under vacuum, the yellowish-white solid 
was dissolved in 30 mL of chloroform and extracted four times against 40 mL 1.0 g mL-1 
potassium hydroxide solution. The organic phase was separated and chloroform was 
evaporated. The residual yellowish product had a soft-crystalline consistency. Yield = 
1.62 g (1.51 mmol; 86 %). 
 
6.1.3. Vesicle formation process  
 
Polymer vesicles were formed using the film hydration method. Generally, 25 mg of 
polymer were dissolved in 5 mL ethanol in a 10 mL round-bottom flask. The ethanol was 
evaporated using a Rotavapor R216 (Büchi, Switzerland) at 100 mbar pressure, 40 °C and 
under rotation (90 rpm). Additionally, the polymer film was dried at 4 × 10-2 mbar at 
room temperature for 2 h. For hydration, 5 mL of aqueous solution (water, buffer or 
fluorescent dye solution) were added into the flask and stirred overnight using a 
magnetic stirrer. To homogenize the vesicle size, the vesicle solution was extruded using 
a LIPEX™ extruder (Northern Lipids Inc., Canada). Each solution was extruded twice 
through a nucleopore track-etch membrane with an average pore diameter of 0.4 μm, 
followed by 12 extrusion steps through a nucleopore track-etch membrane with an 
average pore diameter of 0.2 μm (Whatman, GE Healthcare, UK). 
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6.1.4. Characterization techniques 
 
Nuclear magnetic resonance expermients were performed using Bruker spectrometers 
operating at 400 MHz or at 600.13 MHz proton frequency. All samples were dissolved in 
CDCl3 as solvent and as lock substance. Self-diffusion measurements were performed on 
samples listed in Table 2 with the bipolar gradient pulse sequence using a Bruker Avance 
DRX NMR spectrometer operating 600.13 MHz proton frequency. The instrument was 
equipped with a 5-mm broadband inverse probe with a shielded z-gradient coil and a GAB 
gradient amplifier (10 Ampere, maximum gradient strength 52.5 G cm-1). Measurements 
were performed at 298 K and the temperature was calibrated using a methanol standard 
showing accuracy within ± 0.2 K. The gradient strength was calibrated using a Shigemi tube 
filled with H2O to a height of 4.0 mm and imaging this water cylinder. The resulting gradient 
calibration was validated by determining the diffusion coefficient of water at 310 K and 
reproduced the literature value within 5%. 
The diffusion experiments were performed by varying the gradient strength between 2% 
and 95% of the maximum strength in typically 8 or 16 single experiments while keeping 
the diffusion times and gradient lengths constant. The entire experiment was then 
repeated with a different diffusion time (100 ms to 500 ms). The intensity decrease of 
the signal of interest was determined and fitted with a Bruker t1/t2 software package 
suitable for dosy experiments, which is included in the XWINNMR software.  
 
Light scattering was carried out to determine the hydrodynamic (Rh) and the gyration (Rg) 
radius of assembled structures in solution. Dynamic (DLS) and static (SLS) light scattering 
experiments were performed on an ALV goniometer (ALV GmbH, Germany), equipped 
with an ALV He-Ne laser (λ = 632.8 nm). Light scattering measurements were performed 
in 10 mm cylindrical quartz cells at angles of 40 – 140° at 293 K. For DLS and SLS data 
processing we used the ALV static & dynamic fit and plot software (version 4.31 10/01). 
SLS data were processed according the Guinier-model. 
 
Transmission electron microscopy (TEM). Vesicle solutions were negatively stained with 2% 
uranyl acetate solution and deposited on a carbon-coated copper grid. The samples were 
examined with a transmission electron microscope (Philips Morgagni 268D) operated at 
80 kV. 
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Cryo-transmission electron microscopy (Cryo-TEM). A 4 µL aliquot of sample was adsorbed 
onto a holey carbon-coated grid (Quantifoil, Germany), blotted with Whatman 1 filter 
paper and vitrified into liquid ethane at -178 °C using a Vitrobot (FEI company, 
Netherlands). Frozen grids were transferred onto a Philips CM200-FEG electron 
microscope using a Gatan 626 cryo-holder. Electron micrographs were recorded at an 
accelerating voltage of 200 kV and a magnification of 20 000 x, using a low-dose system 
(10 e-/Å2) while keeping the sample at -172 °C. Micrographs were recorded on a 2K x 2K 
CCD camera (Gatan, USA). 
 
Laser scanning microscopy and fluorescence correlation spectroscopy. Laser scanning 
microscopy (LSM) and fluorescence correlation spectroscopy (FCS) were performed with 
an inverted confocal fluorescence laser scanning microscope LSM 510 META/Confocor2 
(Zeiss, Germany) equipped with an argon laser (for 405, 458, 477, 488 and 514 nm), and 
two helium-neon lasers (543 and 633 nm) as excitation sources. For FCS, 15 μL of sample 
were applied to the glass surface of a cover glass (Huber & Co. AG, Switzerland) which 
was positioned on the xy-stage of the microscope. The excitation laser beam and the 
fluorescence emission passed through the same objective. The fluorescence signal was 
detected by highly sensitive avalanche photo diodes. Fluorescence intensity fluctuations 
were processed in terms of an autocorrelation function. Evaluation of FCS data was 
performed as described previously.[2] 
 
Matrix-assisted laser desorption / ionization mass spectroscopy  time of flight. Spectra were 
recorded on a Voyager-DE Pro instrument (Perseptive Biosystems). The irradiation source 
was a pulsed nitrogen laser with λ = 337 nm. The measurements were carried out using 
the following conditions: reflector operation mode; polarity-positive mode, mass-high 
(20 kV acceleration voltage), 200 pulses per spectrum. The delayed extraction technique 
was used applying the delay time of 200 ns. The matrix was dithranol and the 
measurements were performed using a gold plate. 
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6.1.5. Modification of polymersomes and ligands 
 
Alexa Fluor 633 modification of polymer vesicles. 3.0 mL of vesicle solution with a polymer 
concentration of 0.5 mg mL-1 were produced in 0.1 M sodium bicarbonate buffer 
(pH 8.3). The polymer composition was varied from 0.3% AB-NH / 99.97% AB-OH to 100% 
AB-NH / 0% AB-OH. Detailed information on polymersome composition is shown in 
Table 9.  
 
Table 9. Composition and volumes of polymer solutions in ethanol for preparation of 
polymersomes with varying molar percentages of AB-NH. The stock solutions used to prepare the 
polymer films were the following: (A) AB-OH, 0.3 mg mL
-1
, (B) AB-NH, 60 μg mL
-1
 and (C) AB-NH, 0.3 
mg mL
-1
; solvent for all solutions was ethanol. 
AB-OH 
[%] 
(A) 
[mL] 
AB-NH 
[%] 
(B) 
[μL] 
(C) 
[mL] 
100 5 - - - 
0 - 100 - 5 
70 3.5 30 - 1.5 
90 4.5 10 2500 - 
97 4.85 3 750 - 
99 4.95 1 250 - 
99.7 4.985 0.3 75 - 
99.9 4.995 0.1 25 - 
99.97 4.999 0.03 7.5 - 
 
To 1.0 mL of each solution, 10 μL of 50 µM Alexa633-NHS was added. After 2 h reaction 
time at room temperature, the vesicle solutions were transferred into dialysis 
membranes (MWCO 300 kDa, Spectrum Laboratories Inc., USA) and dialyzed extensively 
against a 0.1 M sodium chloride solution. Measurements were performed by FCS using a 
633 nm He/Ne laser excitation source. 
 
4-formylbenzoate modification of polymer vesicles. 3.0 mL polymersome solution with a 
polymer concentration of 1.5 g mL-1 was produced in 0.1 M sodium bicarbonate buffer 
(pH 8.3). The polymer composition was 3% AB-NH and 97% AB-OH. To 1.0 mL of 
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polymersome solution, 20 µL of 10 mg mL-1 (0.81 µmol) 4-formylbenzoate (S-4FB) in 
DMSO were added. After 2 h reaction time at room temperature, the vesicle solution was 
transferred into a dialysis membrane (MWCO: 300 kDa) and dialyzed extensively against 
0.1M NaCl. In a last step, the solvent was exchanged by dialysis with conjugation buffer 
(0.1 M sodium phosphate buffer pH 6.0). 
 
6-hydrazinonicotinate acetone hydrazone modification of enhanced yellow fluorescence 
protein (eYFP). eYFP was expressed in and purified from E. coli. The concentration of the 
protein was measured with a NanoDrop 2000c system (ThermoFisher Scientific, USA). 
eYFP was obtained in 0.1 M sodium phosphate buffer pH 6.0 at a concentration of 
57.1 mg mL-1 (2.1 mM). 
Primary amino groups of eYFP were modified with succinimidyl 6-hydrazinonicotinate 
acetone hydrazone (S-HyNic). For this, 80 µL 2.1 mM eYFP were incubated with 120 µL 
5.8 mM (4.1 equivalents) HyNic in modification buffer pH 7.4 for 2.5 h under gentle 
stirring at room temperature. Non-reacted S-HyNic was separated from modified eYFP-
HyNic conjugate by diafiltration three times using Amicon Ultra 30K centrifugal filters 
(regenerated cellulose, MWCO: 30 kDa, Millipore, USA) with conjugation buffer. After the 
last diafiltration step, the concentration of the eYFP was determined by UV/Vis to be 
690 μM with a final volume of 200 µL. 
 
6-hydrazinonicotinate acetone hydrazone modification of antibodies. Concentrations and 
volumes of antibodies after washing and quantities of NHS-HyNic solution used for 
modification, including the resulting molar substitution ratio (MSR), are shown in 
Table 10.  
 
Table 10. Concentrations and volumes of antibodies after washing and quantities of S-HyNic 
solution used for modification and resulting MSR. 
Sample 1st washing 
[µM; µL] 
S-HyNic 
[mM; µL] 
2nd washing 
[µM; µL] 
MSR 
[-] 
Anti-biotin IgG 7.0; 100 3.4; 4.1 1.9; 200 5.4 
Trastuzumab IgG 16.7; 930 34.4; 2.5 21.5; 500 3.1 
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The lyophilized antibody was dissolved in and washed with PBS buffer pH 7.4 in Amicon 
Ultra 30 K centrifugal filters. Thereafter, we measured the antibody concentration and 
added S-HyNic solution in DMF. After 90 minutes reaction at room temperature, the IgG-
HyNic solution was washed five times with Amicon Ultra centrifugal filters with 0.1 M 
sodium phosphate buffer pH 6.0. The concentration of IgG and the MSR of HyNic to IgG 
were measured by UV/Vis spectroscopy. For MSR determination, the IgG-HyNic solutions 
were reacted with 4-nitrobenzaldehyde (4-NB) and the specific absorbance was 
measured at 390 nm (Figure 31). 
 
Figure 31. UV-Vis spectrograph of (a) 6-hydrazinonicotinate acetone hydrazone modified anti-
biotin antibody reacted with 4-nitrobenzaldehyde (λmax 390 nm) and (b) 4-formylbenzoate 
modified polymersomes after dialysis reacted with 4-hydrazinonicotinate acetone hydrazone 
(λmax 350 nm). 
 
PolyG23 modification of polymersomes by click-chemistry. ABA1, ABA2, and ABA-SRB were 
mixed in weight ratios of 16/3.7/1 and polymersome solutions with a final polymer 
concentration of 4 mg mL-1 were prepared. To 1.5 mL polymersome solution in bidistilled 
water, the azide-functional poly(G)23 ligand, sodium ascorbate solution, CuSO4 solution, 
and a Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl] amine (TBTA) solution at a volume ratio 
of: 25/120/2/1/1/1 using concentrations mentioned elsewhere.[3] As control sample, a 
polymersome solution without addition of azide-functional poly(G)23 was used. 
 
6.1.6. Microcontact printing 
 
The microcontact printing of the biotin-bovine serum albumin pattern to the cover glass 
slide was performed according to a previously published protocol.[4] The polymersome-
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anti-biotin-IgG conjugate solution (0.1 M sodium phosphate buffer pH 7.4) was incubated 
for 1 h on the patterned glass surface before washing three times with PBS buffer pH 7.4.  
 
6.1.7. THP-1 cell experiments 
 
Two days prior to imaging, THP-1 cells were activated with phorbol-12-myristate-13-
acetate (PMA, 100 nM) to differentiate the monocytes into macrophages and 
approximately 500 000 cells/mL were seeded into each well of the tissue culture slide 
(Lab-tek, NUNC). Both Poly(G)23-modified and control ABA nanocontainers (lacking the 
ligand) were added to the activated cells and incubated (37°C, 5% CO2) for 1, 2, 4, and 24 
hours, respectively. Confocal fluorescence imaging using the 543 nm laser line of a ZEISS 
LSM 510 microscope was used to determine the extent of specific cellular uptake. 
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6.1.8. SKBR3 cell experiments 
 
Cell culture. SKBR3 cells were cultured in DMEM growth medium supplemented with 10% 
fetal bovine serum, 1% penicillin (10,000 units mL-1), streptomycin (10,000 µg mL-1), 
2 mM L-glutamine and 1 mM pyruvate. Cells were grown in a humidified incubator (HERA 
Cell 150, Thermo Scientific, Germany) at 37 °C in a 5% CO2 atmosphere. The medium was 
replenished every two day and the cells were subcultured by trypsinization. 
Targeted uptake of polymersome-antibody conjugates. Cells were seeded at a density of 
1 × 105 cells per well in a 6-well plate and incubated for 24 h to allow attachment of cells 
to the plate prior to the uptake experiments. SKBR3 cells were then incubated with 
sulforhodamine B containing polymersomes (1000 µg mL-1) with and without conjugated 
trastuzumab for 1 h and 2 h at 37 °C in a humidified 5% CO2 incubator. After harvesting 
by trypsinization, the resulting cells were washed with PBS to remove non-internalized 
polymersomes. The cells were analyzed for the uptake of polymersome with and without 
conjugated trastuzumab with confocal laser scanning microscopy and flow cytometry.  
Cell imaging by laser scanning microscopy. SKBR3 cells pre-treated with sulforhodamine B 
containing polymersomes with and without conjugated trastuzumab were further 
incubated at 37 °C with freshly prepared Deep Red (CellmaskTM) plasma membrane stain 
(5 µg mL-1) for 5 min. They were then washed with PBS buffer and visualized with a 
confocal laser scanning microscope (Carl Zeiss LSM510) equipped with 63× water 
emulsion lens (Olympus). The measurements were performed in multi-track mode, and 
the intensity of each fluorescent dye was adjusted individually: sulforhodamine B excited 
at 543 nm in channel 3, Deep Red excited at 633 nm in channel 2. The images were 
processed using Carl Zeiss LSM software (version 3.99) and ImageJ (version 1.43u). 
Flow cytometry. The uptake of polymersome-trastuzumab conjugates and polymersomes 
by SKBR3 cells was analyzed via flow cytometry (CYAN, Beckman Coulter, USA) based on 
the measurement of cellular-associated fluorescence of cells (1 × 105) and the mean 
fluorescence intensity of gated viable cells. A total of 20 000 events were analyzed for 
each condition.  
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In vitro cell proliferation inhibition activity of polymersome-trastuzumab conjugates. SKBR3 
cells at a density of 1 × 104 cells per well were cultured in a 96-well plate and incubated 
with different concentrations of polymersomes and polymersome-trastuzumab 
conjugates (10, 30, 100, 300 µg mL-1 polymer concentration) for 24 h at 37 °C and 5% CO2 
atmosphere. The proliferation inhibition activity was determined by the MTS (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) 
assay. This assay measures the dehydrogenase activity of viable cells by the reduction of 
MTS to a colored product, formazan. Subsequently, 20 μL of CellTiter 96 AQueous One 
Solution Cell Proliferation Assay (MTS) reagent (Promega) were added to each well and 
then incubated for 2 h. The absorbance of each well mixture was measured with a 
microplate reader (Spectramax M5, Molecular Devices, USA) at λ = 490 nm. The 
untreated control cells were considered as 100% viable and cell proliferation after 
treatment with polymersome and polymersome-trastuzumab conjugate was calculated 
from [Asample / Acontrol] X 100. Errors are standard deviations of triplicate of samples. 
 
6.1.9. Formation/complexation with cPDMS  
 
For the preparation of cPDMS-vesicle solutions, lower polymer concentrations were required 
than for common block copolymer vesicle solutions. By the film hydration method we 
formed vesicle solutions of 1 mg mL-1, using different salts or Dulbecco’s Phosphate Buffered 
Saline. Before film formation, 2 µL of 10 µM BODIPY 630/650 in DMSO was added. The final 
volume of the aqueous vesicle solution was 2.0 mL. All solutions were investigated 
immediately after their preparation. 
The complexation of cPDMS with siRNA was performed using CyTM3 labeled GAPDH siRNA 
(Applied Biosystems/Ambion, USA). Vesicles were prepared as described before, but 
exclusively in Dulbecco’s Phosphate Buffered Saline. 10 µL of 5 nM siRNA solution was added 
to 40 μL of 0.1 mg mL-1 vesicle solution and slightly shaken for 5 min. For the experiment 
where siRNA was added before vesicle formation, 20 µL of 5 nM siRNA solution was added 
to 80 μL Dulbecco’s Phosphate Buffered Saline before adding to a cPDMS film of 10 µg. The 
film was hydrated for 1 hour. 
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8. Appendix 
 
Figure 32 
1
H NMR spectrum of PDMS as received from ABCR GmbH 
 
PDMS: 
1
H NMR (600.1 MHz, CDCl3) δ/ppm = 3.80 – 3.70 (m, 2H), 3.60 – 3.50 (m, 2H), 
3.5 – 3.4 (m, 2H), 1.96 (t, 1H), 1.70 – 1.55 (bm, 2H), 1.40 – 1.25 (m, 4H), 0.88 (t, 3H), 
0.58 – 0.50 (m, 4H), 0.25 –  -0.1 (bs, 3H) 
 
 
Figure 33 
1
H NMR spectrum of the PDMS-b-PMOXA AB-OH 
 
AB-OH: 
1
H NMR (600.1 MHz, CDCl3) δ/ppm = 3.80 – 3.70 (m, 2H), 3.60 – 3.30 (bm, 8H), 
2.25 – 2.05 (bm, 3H), 1.80 – 1.70 (m, 4H), 1.65 – 1.55 (bm, 2H), 1.40 – 1.25 (m, 4H), 0.88 
(t, 3H), 0.58 – 0.50 (m, 4H), 0.25 –  -0.1 (bs, 3H) 
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Figure 34 
1
H NMR spectrum of the PDMS-b-PMOXA AB-NH 
 
AB-NH: 
1
H NMR (600.1 MHz, CDCl3) δ/ppm = 3.70 – 3.30 (bm, 10H), 3.30 – 3.15 (m, 2H), 
2.85 – 2.75 (m, 2H), 2.65 – 2.55 (m, 2H), 2.25 – 2.05 (bm, 3H), 1.80 – 1.70 (bs, 1H), 1.60 –
 1.50 (bm, 2H), 1.50 – 1.20 (m, 4H), 0.88 (t, 3H), 0.58 – 0.50 (m, 4H), 0.25 – -0.1 (bs, 3H) 
 
 
 
Figure 35. Gunier plot of polymersomes consisting of ABA-1 in water 
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Figure 36. 
1
H NMR spectrum of the PMOXA-b-PDMS-b-PMOXA ABA-1 
 
ABA-1: 
1
H NMR (400 MHz, CDCl3) δ/ppm = 3.80 – 3.20 (bm, 12H), 2.25 – 2.05 (bm, 6H), 
1.40 – 1.20 (bm, 4H), 0.58 – 0.50 (m, 4H), 0.30 – 0.0 (bs, 3H) 
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Figure 37. 
1
H NMR spectrum of the PMOXA-b-PDMS-b-PMOXA ABA-2 (top); The proton shifts of 
the N-methylpropargylamine conjugated to the PMOXA is shown in the range between 2.5 and 3.0 
ppm (bottom). 
 
ABA-2: 
1
H NMR (400 MHz, CDCl3) δ/ppm = 3.70 – 3.20 (bm, 12H), 2.73 (d, 2H), 2.60 (m, 
4H), 2.35 (m, 4H), 2.25 – 2.05 (bm, 6H), 1.40 – 1.20 (bm, 4H), 0.58 – 0.50 (m, 4H), 0.25 –
 0.1 (bs, 3H) 
